Method and Pesticidal Mixtures for Controlling Pentatomidae Pests

ABSTRACT

The invention further relates to certain of these mixtures.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No.15/519,278, filed Apr. 14, 2017, the entire contents of which are herebyincorporated herein by reference. U.S. application Ser. No. 15/519,278is a National Stage application of International Application No.PCT/EP2015/074067, filed Oct. 16, 2015, which claims the benefit of U.S.Provisional Application No. 62/064,493, filed Oct. 16, 2014, the entirecontents of both of which are hereby incorporated herein by reference.

The invention relates to a method for controlling Pentatomidae pests,particularly in soybean crops, by applying a pesticidal mixturecomprising insecticidal components of the ginkgo tree. The inventionfurther relates to pesticidal mixtures comprising insecticidalcomponents of the ginkgo tree, their production and uses thereof.

Stink bugs (order of Hemiptera, family of Pentatomidae) are animal pestsand true bugs. They are probably one of the most common pest problems insoybean (Stewart et al., Soybean Insects—Stink bugs, University ofTennessee Institute of Agriculture, W200 09-0098).

Stink bugs feed on over 52 plants, including native and ornamentaltrees, shrubs, vines, weeds, and many cultivated crops such as corn andcotton, as well as numerous uncultivated plants, and their preferredhosts are nearly all wild plants. They build up on these hosts and moveto soybeans late in the season as their preferred foods mature.

Stink bugs may feed on many parts of the plant, however they typicallytarget developing seed including the pods, meaning that injury tosoybean seed is the primary problem associated with stink buginfestations.

Control of stinkbugs in soybean is often vital to prevent significanteconomic damage.

Insecticides commonly used to control stinkbugs include pyrethroids,neonicotinoids and organophosphates, though pyrethroid insecticides areusually the method of choice for controlling stink bugs in soybean.However, there are increasing problems with insecticide resistance,particularly in brown stink bug populations and particularly topyrethroids. Euschistus heros can also be difficult to manage usingorganophosphates or endosulfan (Sosa-Gomez et al., 2009). There istherefore a need for effective ecological methods of controllingstinkbugs in soybean.

Particularly insecticides acting on the gamma-aminobutyric acid(GABA)-gated chloride channel (disclosed in e.g. WO 2005/085216(EP1731512), WO2009/002809 and WO2009/080250) seem to be effective forcontrolling stinkbugs, especially in soybean such as described inWO2012/104331.

One typical problem arising in the field of pest control lies in theneed to reduce the dosage rates of the active ingredient in order toreduce or avoid unfavorable environmental or toxicological effectswhilst still allowing effective pest control.

Another problem encountered concerns the need to have available pestcontrol agents which are effective against a broad spectrum of pests.

There also exists the need for pest control agents that combineknock-down activity with prolonged control, that is, fast action withlong lasting action.

Another difficulty in relation to the use of pesticides is that therepeated and exclusive application of an individual pesticidal compoundleads in many cases to a rapid selection of pests which have developednatural or adapted resistance against the active compound in question.Therefore there is a need for pest control agents that help prevent orovercome resistance.

It was therefore an object of the present invention to providepesticidal mixtures for the control of Pentatomidae pests which solve atleast one of the discussed problems such as reducing the dosage rate,enhancing the spectrum of activity or combining knock-down activity withprolonged control or as to resistance management.

It has been found that this object is in part or in whole achieved byapplying the combination of active components of the ginkgo tree andfurther pesticides defined below.

Further it has been found that mixtures of the specific activecomponents of the ginkgo tree and further insecticidal and/or fungicidalcompounds show synergistic effect in the contest of various pests andfungi.

Accordingly, in one aspect of the invention there is provided a methodfor controlling pests from the family of Pentatonidae, comprising thestep of contacting the pests, their food supply, habitat or breedinggrounds with a pesticidal mixture comprising as active compounds

-   1) at least one compound I, which is a component of the ginkgo tree    selected from the group consisting of bilobalide, ginkgolide A,    ginkgolide B, ginkgolide C, ginkgolide J and ginkgolide M,-   and-   at least one pesticidally active compound II selected from groups M    and/or L consisting of-   II-M.1 Acetylcholine esterase inhibitors:-   II-M.1A carbamates: aldicarb, alanycarb, bendiocarb, benfuracarb,    butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan,    ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb,    methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur,    thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate;    and-   II-M.1B organophosphates, for example acephate, azamethiphos,    azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos,    chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl,    coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP,    dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion,    ethoprophos, famphur, fenamiphos, fenitrothion, fenthion,    fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl    O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion,    mecarbam, methamidophos, methidathion, mevinphos, monocrotophos,    naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl,    phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim,    pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos,    pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos,    terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and    vamidothion;-   II-M.2. GABA-gated chloride channel antagonists:-   II-M.2A cyclodiene organochlorine compounds: endosulfan or    chlordane; and-   II-M.2B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole and    pyriprole;-   II-M.3 Sodium channel modulators:-   II-M.3A pyrethroids: acrinathrin, allethrin, d-cis-trans allethrin,    d-trans allethrin, bifenthrin, bioallethrin, bioallethrin    S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin,    beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin,    cypermethrin, alpha-cypermethrin, beta-cypermethrin,    theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin,    empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate,    flucythrinate, flumethrin, tau-fluvalinate, halfenprox,    heptafluthrin, imiprothrin, meperfluthrin, metofluthrin,    momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin,    pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin,    tetramethylfluthrin, tetramethrin, tralomethrin, and transfluthrin;    and-   II-M.3B sodium channel modulators: DDT, and methoxychlor;-   II-M.4 Nicotinic acetylcholine receptor agonists:-   II-M.4A neonicotinoids: acetamiprid, clothianidin, cycloxaprid,    dinotefuran, imidacloprid, nitenpyram, thiacloprid, and    thiamethoxam;-   II-M.4A.2    (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide;-   II-M.4.A.3    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine;    and-   II-M.4B nicotine;-   II-M.5 Nicotinic acetylcholine receptor allosteric activators from    the class of spinosyns: spinosad, and spinetoram;-   II-M.6 Chloride channel activators from the class of avermectins and    milbemycins: abamectin, emamectin benzoate, ivermectin, lepimectin,    and milbemectin;-   II-M.7 Juvenile hormone mimics:-   II-M.7A juvenile hormone analogues: hydroprene, kinoprene, and    methoprene; and-   II-M.7B fenoxycarb, and pyriproxyfen;-   II-M.8 miscellaneous non-specific inhibitors:-   II-M.8A alkyl halides: methyl bromide, and other alkyl halides; and-   II-M.8B chloropicrin, sulfuryl fluoride, borax, and tartar emetic;-   II-M.9 Selective homopteran feeding blockers: pymetrozine, and    flonicamid;-   II-M.10 Mite growth inhibitors: clofentezine, hexythiazox,    diflovidazin, and etoxazole;-   II-M.11 Microbial disruptors of insect midgut membranes: Bacillus    thuringiensis, Bacillus sphaericus, and the insecticdal proteins    they produce: Bacillus thuringiensis subsp. israelensis, Bacillus    sphaericus, Bacillus thuringiensis subsp. aizawai and Bacillus    thuringiensis subsp. tenebrionis, or the Bt crop proteins: Cry1Ab,    Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1;-   II-M.12 Inhibitors of mitochondrial ATP synthase:-   II-M.12A diafenthiuron, and organotin miticides: azocyclotin,    cyhexatin, and fenbutatin oxide; and-   II-M.12B propargite, and tetradifon;-   II-M.13 Uncouplers of oxidative phosphorylation via disruption of    the proton gradient: chlorfenapyr, DNOC, and sulfluramid;-   II-M.14 Nicotinic acetylcholine receptor channel blockers:    bensultap, cartap hydrochloride, thiocyclam, and thiosultap sodium;-   II-M.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron,    chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron,    hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and    triflumuron;-   II-M.16 Inhibitors of the chitin biosynthesis type 1: buprofezin;-   II-M.17 Moulting disruptors: cyromazine;-   II-M.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide,    halofenozide, fufenozide or chromafenozide;-   II-M.19 Octopamin receptor agonists: amitraz;-   II-M.20 Mitochondrial complex III electron transport inhibitors:    hydramethylnon, acequinocyl, and fluacrypyrim;-   II-M.21 Mitochondrial complex I electron transport inhibitors:-   II-M.21A METI acaricides and insecticides: fenazaquin,    fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and    tolfenpyrad; and-   II-M.21B rotenone;-   II-M.22 Voltage-dependent sodium channel blockers:-   II-M.22A indoxacarb;-   II-M.22B metaflumizone;-   II-M.22B.1    2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide;    and-   II-M.22B.2    N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;-   II-M.23 Inhibitors of the of acetyl CoA carboxylase of the class of    tetronic and tetramic acid derivatives: spirodiclofen, spiromesifen,    and spirotetramat;-   II-M.24 Mitochondrial complex IV electron transport inhibitors:-   II-M.24A phosphorous compounds: aluminium phosphide, calcium    phosphide, phosphine, and zinc phosphide; and-   II-M.24B cyanide;-   II-M.25 Mitochondrial complex II electron transport inhibitors from    the class of beta-ketonitrile derivatives: cyenopyrafen, and    cyflumetofen;-   II-M.28 Ryanodine receptor-modulators from the class of diamides:    flubendiamide, chlorantraniliprole (Rynaxypyr®), cyantraniliprole    (Cyazypyr®), tetraniliprole; and the phthalamide compounds-   II-M.28.1    (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid;-   II-M.28.2    (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid;-   II-M.28.3    3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide    (proposed ISO name: cyclaniliprole);-   II-M.28.4    methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}-amino)benzoyl]-1,2-dimethylhydrazinecarboxylate;-   II-M.28.5a    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   IIM.28.5b    N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5c    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5d    N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5h    N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5i    N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5j    3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide;-   II-M.28.5k    3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5l    N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide;    and 11-M.28.6: cyhalodiamide;-   II-M.29. insecticidal active compounds of unknown or uncertain mode    of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet,    benzoximate, bifenazate, broflanilide, bromopropylate,    chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim,    flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone,    fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide,    pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, and    triflumezopyrim;-   II-M.29.3:    11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one;-   II-M.29.4:    3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one;-   II-M.29.5:    1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine,    and actives on basis of Bacillus firmus (Votivo, 1-1582); and-   II-M.29.6a    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6b    (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6c    (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide;-   II-M.29.6d    (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6e    (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6f    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.29.6g    (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.29.6h    (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide-   II-M.29.6i    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoropropanamide.);-   II-M.29.6j    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide;    and-   II-M.29.6k    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine;-   II-M.29.8: fluazaindolizine;-   II-M.29.9.a    4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide;    and-   II-M.29.9.b fluxametamide;-   II-M.29.10    5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole;-   II-M.29.11.b    3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide;-   II-M.29.11.c    3-(benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide;-   II-M.29.11.d    N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.e    N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide;-   II-M.29.11.f    4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.g    3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.h    2-chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide;-   II-M.29.11.i    4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.j    4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide;-   II-M.29.11.k    N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.l    N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.m    N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.n    4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.o    4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.p    N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.12.a    2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine;-   II-M.29.12.b    2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.29.12.c    2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.29.12.d N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide;-   II-M.29.12.e N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide;-   II-M.29.12.f    N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.g N-M    ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.h    N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.i    N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.j    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide;-   II-M.29.12.k    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide;-   II-M.29.12.l    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide;-   II-M.29.12.m    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide;    or the compounds-   II-M.29.14a    1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine;-   II-M.29.14b    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol;-   II-M.29.16a    1-isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or-   II-M.29.16b 1-(1,2-dimethyl    propyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16c    N,5-dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide;-   II-M.29.16d    1-[1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16e    N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16f    1-(1,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16g    1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16h    N-methyl-1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16i    1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;    and-   II-M.29.16j    1-(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.17a    N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17b N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17c N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17d    2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide;-   II-M.29.17e    2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide;-   II-M.29.17f methyl    2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate;-   II-M.29.17g    N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.17h    N-(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.17i    2-(3-pyridinyl)-N-(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide;    and-   II-M.29.17j    N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.18a    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)propanamide;-   II-M.29.18b    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)propanamide;-   II-M.29.18c    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfanyl]-N-ethyl-propanamide;    and-   II-M.29.18d    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl-propanamide;-   II-M.29.19 sarolaner;-   II-M.29.20 lotilaner;-   II-L Biopesticides:-   II-L.1 Microbial pesticides with fungicidal, bactericidal, viricidal    and/or plant defense activator activity: Ampelomyces quisqualis,    Aspergillus flavus, Aureobasidium pullulans, Bacillus    altitudinis, B. amyloliquefaciens, B. megaterium, B. mojavensis, B.    mycoides, B. simplex, B. solisalsi, B. subtilis, B. subtilis var.    amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter    michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria    parasitica, Cryptococcus albidus, Dilophosphora alopecur Fusarium    oxysporum, Clonostachys rosea f. catenulate (also named Gliocladium    catenulatum), Gliocladium roseum, Lysobacter antibioticus, L.    enzymogenes, Metschnikowia fructicola, Microdochium dimerum,    Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa,    Pantoea vagans, Penicillium bilaiae, Phlebiopsis gigantea,    Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa,    Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica,    Streptomyces griseoviridis, S. lydicus, S. violaceusniger,    Talaromyces flavus, T. asperellum, T. atroviride, T. fertile, T.    gamsii, T. harmatum, T. harzianum, T. polysporum, T. stromaticum, T.    virens, T. viride, Typhula phacorrhiza, Ulocladium oudemansii,    Verticillium dahlia, and zucchini yellow mosaic virus (avirulent    strain);-   II-L.2 Biochemical pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: harpin protein,    and Reynoutria sachalinensis extract;-   II-L.3 Microbial pesticides with insecticidal, acaricidal,    molluscidal and/or nematicidal activity: Agrobacterium radiobacter,    Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp.    aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp.    tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia spp.,    Chromobacterium subtsugae, Cydia pomonella granulovirus (CpGV),    Cryptophlebia leucotreta granulovirus (CrleGV), Flavobacterium spp.,    Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea    nucleopolyhedrovirus (HzNPV), Helicoverpa zea single capsid    nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, Isaria    fumosorosea, Lecanicillium longisporum, L. muscarium, Metarhizium    anisopliae, Metarhizium anisopliae var. anisopliae, M. anisopliae    var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P.    lilacinus, Paenibacillus popilliae, Pasteuria spp., P.    nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae,    Pseudomonas fluorescens, Spodoptera littoralis nucleopolyhedrovirus    (SpliNPV), Steinernema carpocapsae, S. feltiae, S. kraussei    Streptomyces galbus, and S. microflavus;-   II-L.4 Biochemical pesticides with insecticidal, acaricidal,    molluscidal, pheromone and/or nematicidal activity: L-carvone,    citral, (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate,    (E,Z)-2,4-ethyl decadienoate (pear ester),    (Z,Z,E)-7,11,13-hexadecatrienal, heptyl butyrate, isopropyl    myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1-butanol,    methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1-ol,    (E,Z)-2,13-octadecadien-1-ol acetate, (E,Z)-3,13-octadecadien-1-ol,    R-1-octen-3-ol, pentatermanone, (E,Z,Z)-3,8,11-tetradecatrienyl    acetate, (Z,E)-9,12-tetradecadien-1-yl acetate,    Z-7-tetradecen-2-one, Z-9-tetradecen-1-yl acetate,    Z-11-tetradecenal, Z-11-tetradecen-1-ol, extract of Chenopodium    ambrosiodes, Neem oil, and Quillay extract;-   II-L.5 Microbial pesticides with plant stress reducing, plant growth    regulator, plant growth promoting and/or yield enhancing    activity: A. lipoferum, A. irakense, A. halopraeferens, B. elkani B.    liaoningense, B. lupini Delftia acidovorans, Glomus intraradices,    Mesorhizobium spp., Rhizobium leguminosarum bv. phaseoli, R. l. bv.    trifolii, R. l. bv. viciae, R. tropici, and Sinorhizobium meliloti;-   and/or at least one fungicidally active compound III selected from-   III-F.I Respiration inhibitors-   III-F.I1 Inhibitors of complex III at Q_(o) site: azoxystrobin,    coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin,    fenaminstrobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin,    kresoxim-methyl, mandestrobin, metominostrobin, orysastrobin,    picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin,    trifloxystrobin,    2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide,    pyribencarb, triclopyricarb/chlorodincarb, famoxadone, and    fenamidone,    methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate,    1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyltetrazol-5-one,    1-[2-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one,    1-[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one,    1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methyl    pyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one,    1-methyl-4-[3-methyl-2-[[1-[3-(trifluoromethyl)phenyl]-ethylideneamino]oxy-methyl]phenyl]tetrazol-5-one,    (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide,    (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide,    and    (Z,2E)-5-[1-(4-chloro-2-fluoro-phenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide;-   III-F.I2 inhibitors of complex III at Q_(i) site: cyazofamid,    amisulbrom,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxypyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate;    (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl    2-methylpropanoate, and    (3S,6S,7R,8R)-8-benzyl-3-[3-[(isobutyryloxy)methoxy]-4-methoxypicolinamido]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl    isobutyrate;-   III-F.I3 inhibitors of complex II: benodanil, benzovindiflupyr,    bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil,    fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil,    oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam,    thifluzamide,    N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,    N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3,5-trimethyl-N-(1,1,3-trimethyl    indan-4-yl)pyrazole-4-carboxamide,    N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide,    and    N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide;-   III-F.I4 other respiration inhibitors: diflumetorim,    (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine;    -   nitrophenyl derivates: binapacryl, dinobuton, dinocap,        fluazinam, ferimzone; organometal compounds: fentin-acetate,        fentin chloride, and fentin hydroxide; ametoctradin; and        silthiofam;-   III-F.II Sterol biosynthesis inhibitors:-   III-F.II1 C14 demethylase inhibitors:    -   triazoles: azaconazole, bitertanol, bromuconazole,        cyproconazole, difenoconazole, diniconazole, diniconazole-M,        epoxiconazole, fenbuconazole, fluquinconazole, flusilazole,        flutriafol, hexaconazole, imibenconazole, ipconazole,        metconazole, myclobutanil, oxpoconazole, paclobutrazole,        penconazole, propiconazole, prothioconazole, simeconazole,        tebuconazole, tetraconazole, triadimefon, triadimenol,        triticonazole, uniconazole,        1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazolo,        2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,        1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,        2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pent-3-yn-2-ol;        imidazoles: imazalil, pefurazoate, prochloraz, triflumizol;    -   pyrimidines, pyridines and piperazines: fenarimol, nuarimol,        pyrifenox, triforine, and        [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;-   III-F.II2 Delta14-reductase inhibitors: aldimorph, dodemorph,    dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin,    piperalin, and spiroxamine;-   III-F.II3 Inhibitors of 3-keto reductase: fenhexamid;-   III-F.II Nucleic acid synthesis inhibitors-   III-F.III1 phenylamides or acyl amino acid fungicides: benalaxyl,    benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace,    and oxadixyl;-   III-F.III2 others: hymexazole, octhilinone, oxolinic acid,    bupirimate, 5-fluorocytosine,    5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, and    5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;-   III-F.IV Inhibitors of cell division and cytoskeleton-   III-F.IV1 tubulin inhibitors from the class of    -   benzimidazoles, and thiophanates: benomyl, carbendazim,        fuberidazole, thiabendazole, and thiophanatemethyl;    -   triazolopyrimidines:        5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine;        and-   III-F.IV2 other cell division inhibitors: diethofencarb, ethaboxam,    pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;-   III-F.V Inhibitors of amino acid and protein synthesis:-   III-F.V1 methionine synthesis inhibitors from the class of    anilino-pyrimidines: cyprodinil, mepanipyrim, and pyrimethanil; and-   III-F.V2 protein synthesis inhibitors: blasticidin-S, kasugamycin,    kasugamycin hydrochloridehydrate, mildiomycin, streptomycin,    oxytetracyclin, polyoxine, and validamycin A;-   III-F.VI Signal transduction inhibitors:-   III-F.VI1 MAP/histidine kinase inhibitors: fluoroimid, iprodione,    procymidone, vinclozolin, fenpiclonil, and fludioxonil; and-   III-F.VI2 G protein inhibitors: quinoxyfen;-   III-F.VII Lipid and membrane synthesis inhibitors:-   III-F.VII1 Phospholipid biosynthesis inhibitors: edifenphos,    iprobenfos, pyrazophos, isoprothiolane;-   III-F.VII2 lipid peroxidation: dicloran, quintozene, tecnazene,    tolclofos-methyl, biphenyl, chloroneb, and etridiazole;-   III-F.VII3 phospholipid biosynthesis and cell wall deposition:    dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb,    iprovalicarb, valifenalate, and    N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic    acid-(4-fluorophenyl) ester;-   III-F.VII4 compounds affecting cell membrane permeability and fatty    acides: propamocarb; and-   III-F.VII5 fatty acid amide hydrolase inhibitors: oxathiapiprolin,    2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl    methanesulfonate,    2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl),    and 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl    methanesulfonate;-   III-F.VIII Inhibitors with Multi Site Action:-   III-F.VIII1 inorganic active substances: Bordeaux mixture, copper    acetate, copper hydroxide, copper oxychloride, basic copper sulfate,    and sulfur;-   III-F.VIII2 thio- and dithiocarbamates: ferbam, mancozeb, maneb,    metam, metiram, propineb, thiram, zineb, and ziram;-   III-F.VIII3 organochlorine compounds from the class of phthalimides,    sulfamides, and chloronitriles: anilazine, chlorothalonil, captafol,    captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene,    pentachlorphenole and its salts, phthalide, tolylfluanid, and    N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide; and-   III-F.VIII4 guanidines and others: guanidine, dodine, dodine free    base, guazatine, guazatineacetate, iminoctadine,    iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon,    and    2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)tetraone;-   III-F.IX Cell wall synthesis inhibitors:-   III-F.IX1 inhibitors of glucan synthesis: validamycin, and polyoxin    B;-   III-F.IX2 melanin synthesis inhibitors: pyroquilon, tricyclazole,    carpropamid, dicyclomet, and fenoxanil;-   III-F.X Plant defence inducers-   III-F.X1 acibenzolar-S-methyl, probenazole, isotianil, tiadinil,    prohexadione-calcium;-   III-F.X2 phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid    and its salts; potassium or sodium bicarbonate; and-   III-F.XI Unknown mode of action:    -   bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet,        debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate,        diphenylamin, fenpyrazamine, flumetover, flusulfamide,        flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl,        oxathiapiprolin, tolprocarb, oxin-copper, proquinazid,        tebufloquin, tecloftalam, triazoxide,        2-butoxy-6-iodo-3-propylchromen-4-one,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl        acetamide,        N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl        formamidine, methoxy-acetic acid        6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl ester,        3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine,        3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine        (pyrisoxazole), N-(6-methoxy-pyridin-3-yl)        cyclopropanecarboxylic acid amide,        5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole,        2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide,        ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox,        pentyl        N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate,        2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol,        2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol,        3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        and 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine;-   in a synergistically effective amount.

Moreover, it has been found that simultaneous, that is joint orseparate, application of the active compound I and one or morecompound(s) II and/or III, or successive application (that isimmediately one after another and thereby creating the mixture “in-situ”on the desired location, as e.g. the plant) of the active compound I andone or more active compound(s) II and/or III allows enhanced control ofpests compared to the control rates that are possible with theindividual compounds.

The invention also provides for the use of a mixture according to theinvention as disclosed above for controlling the pests from the familyof Pentatomidae, preferably Acrosternum spp., Euschistus spp., Nezaraspp and/or Piezodrus spp., in particular Acrosternum hilare, Euschistusheros, Nezara viridula and/or Piezodrus guildini Further is provided theuse of a mixture of the invention as disclosed above for controllingHalyomorpha halys and/or Dichelops spp., such as Dichelops furcatus andDichelops melacanthos.

The mixtures of the invention are partly novel and partly known.Accordingly, the invention also provides for pesticidal mixturescomprising as active compounds

-   1) at least one compound I, which is a component of the ginkgo tree    selected from the group consisting of bilobalide, ginkgolide A,    ginkgolide B, ginkgolide C, ginkgolide J and ginkgolide M, and-   2) at least one pesticidally active compound II selected from groups    M and/or L consisting of-   II-M.1 Acetylcholine esterase inhibitors:-   II-M.1A carbamates: aldicarb, alanycarb, bendiocarb, benfuracarb,    butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan,    ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb,    methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur,    thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate;    and-   II-M.2. GABA-gated chloride channel antagonists:-   II-M.2A cyclodiene organochlorine compounds: endosulfan or    chlordane; and-   II-M.2B fiproles: ethiprole, fipronil, flufiprole, pyrafluprole and    pyriprole;-   II-M.3 Sodium channel modulators:-   II-M.3B sodium channel modulators: DDT, and methoxychlor;-   II-M.4 Nicotinic acetylcholine receptor agonists:-   II-M.4A neonicotinoids: acetamiprid, clothianidin, cycloxaprid,    dinotefuran, imidacloprid, nitenpyram, thiacloprid, and    thiamethoxam;-   II-M.4A.2    (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide;-   II-M4.A.3    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine;    and-   II-M.4B nicotine;-   II-M.5 Nicotinic acetylcholine receptor allosteric activators from    the class of spinosyns: spinosad, and spinetoram;-   II-M.6 Chloride channel activators from the class of avermectins and    milbemycins: abamectin, emamectin benzoate, ivermectin, lepimectin,    and milbemectin;-   II-M.7 Juvenile hormone mimics:-   II-M.7A juvenile hormone analogues: hydroprene, kinoprene, and    methoprene; and-   II-M.7B fenoxycarb, and pyriproxyfen;-   II-M.8 miscellaneous non-specific inhibitors:-   II-M.8A alkyl halides: methyl bromide, and other alkyl halides; and-   II-M.8B chloropicrin, sulfuryl fluoride, borax, and tartar emetic;-   II-M.9 Selective homopteran feeding blockers: pymetrozine, and    flonicamid;-   II-M.10 Mite growth inhibitors: clofentezine, hexythiazox,    diflovidazin, and etoxazole;-   II-M.11 Microbial disruptors of insect midgut membranes: Bacillus    thuringiensis, Bacillus sphaericus, and the insecticdal proteins    they produce: Bacillus thuringiensis subsp. israelensis, Bacillus    sphaericus, Bacillus thuringiensis subsp. aizawai and Bacillus    thuringiensis subsp. tenebrionis, or the Bt crop proteins: Cry1Ab,    Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1;-   II-M.12 Inhibitors of mitochondrial ATP synthase:-   II-M.12A diafenthiuron, and organotin miticides: azocyclotin,    cyhexatin, and fenbutatin oxide; and-   II-M.12B propargite, and tetradifon;-   II-M.13 Uncouplers of oxidative phosphorylation via disruption of    the proton gradient: chlorfenapyr, DNOC, and sulfluramid;-   II-M.14 Nicotinic acetylcholine receptor channel blockers:    bensultap, cartap hydrochloride, thiocyclam, and thiosultap sodium;-   II-M.15 Inhibitors of the chitin biosynthesis type 0: bistrifluron,    chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron,    hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron, and    triflumuron;-   II-M.16 Inhibitors of the chitin biosynthesis type 1: buprofezin;-   II-M.17 Moulting disruptors: cyromazine;-   II-M.18 Ecdyson receptor agonists: methoxyfenozide, tebufenozide,    halofenozide, fufenozide or chromafenozide;-   II-M.19 Octopamin receptor agonists: amitraz;-   II-M.20 Mitochondrial complex III electron transport inhibitors:    hydramethylnon, acequinocyl, and fluacrypyrim;-   II-M.21 Mitochondrial complex I electron transport inhibitors:-   II-M.21A METI acaricides and insecticides: fenazaquin,    fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, and    tolfenpyrad; and-   II-M.21B rotenone;-   II-M.22 Voltage-dependent sodium channel blockers:-   II-M.22A indoxacarb;-   II-M.22B metaflumizone;-   II-M.22B.1    2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide;    and-   II-M.22B.2    N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;-   II-M.23 Inhibitors of the of acetyl CoA carboxylase of the class of    tetronic and tetramic acid derivatives: spirodiclofen, spiromesifen,    and spirotetramat;-   II-M.24 Mitochondrial complex IV electron transport inhibitors:-   II-M.24A phosphorous compounds: aluminium phosphide, calcium    phosphide, phosphine, and zinc phosphide; and-   II-M.24B cyanide;-   II-M.25 Mitochondrial complex II electron transport inhibitors from    the class of beta-ketonitrile derivatives: cyenopyrafen, and    cyflumetofen;-   II-M.28 Ryanodine receptor-modulators from the class of diamides:    flubendiamide, chlorantraniliprole (Rynaxypyr®), cyantraniliprole    (Cyazypyr®), tetraniliprole; and the phthalamide compounds-   II-M.28.1    (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid;-   II-M.28.2    (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid;-   II-M.28.3    3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide    (proposed ISO name: cyclaniliprole);-   II-M.28.4    methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}-amino)benzoyl]-1,2-dimethyl    hydrazinecarboxylate;-   II-M.28.5a    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   IIM.28.5b    N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5c    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5d    N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5h    N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5i    N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5j    3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide;-   II-M.28.5k    3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5l    N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide;    and-   II-M.28.6: cyhalodiamide;-   II-M.29. insecticidal active compounds of unknown or uncertain mode    of action: afidopyropen, afoxolaner, azadirachtin, amidoflumet,    benzoximate, bifenazate, broflanilide, bromopropylate,    chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim,    flometoquin, fluensulfone, fluhexafon, fluopyram, flupyradifurone,    fluralaner, metoxadiazone, piperonyl butoxide, pyflubumide,    pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, and    triflumezopyrim;-   II-M.29.3:    11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one;-   II-M.29.4:    3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one;-   II-M.29.5:    1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine,    and actives on basis of Bacillus firmus (Votivo, 1-1582); and-   II-M.29.6a    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6b    (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6c    (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide;-   II-M.29.6d    (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6e    (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.29.6f    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.29.6g    (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.29.6h    (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide-   II-M.29.6i    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoropropanamide.);-   II-M.29.6j    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide;    and-   II-M.29.6k    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine;-   II-M.29.8: fluazaindolizine;-   II-M.29.9.a    4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide;    and-   II-M.29.9.b fluxametamide;-   II-M.29.10    5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole;-   II-M.29.11.b    3-(benzoylmethylamino)-N-[2-bromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide;-   II-M.29.11.c    3-(benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]-benzamide;-   II-M.29.11.d    N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.e    N-[3-[[[2-bromo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide;-   II-M.29.11.f    4-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.g    3-fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide;-   II-M.29.11.h    2-chloro-N-[3-[[[2-iodo-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-3-pyridinecarboxamide;-   II-M.29.11.i    4-cyano-N-[2-cyano-5-[[2,6-dibromo-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.j    4-cyano-3-[(4-cyano-2-methyl-benzoyl)amino]-N-[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]-2-fluoro-benzamide;-   II-M.29.11.k    N-[5-[[2-chloro-6-cyano-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.l    N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1-hydroxy-1-(trifluoromethyl)ethyl]-phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.m    N-[5-[[2-bromo-6-chloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.11.n    4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,3,3,3-hexafluoro-1-(trifluoromethyl)propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.o    4-cyano-N-[2-cyano-5-[[2,6-dichloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide;-   II-M.29.11.p    N-[5-[[2-bromo-6-chloro-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]-carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;-   II-M.29.12.a    2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine;-   II-M.29.12.b    2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.29.12.c    2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.29.12.d N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide;-   II-M.29.12.e N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide;-   II-M.29.12.f    N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.g N-M    ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.h    N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.i    N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide;-   II-M.29.12.j    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide;-   II-M.29.12.k    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide;-   II-M.29.12.l    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide;-   II-M.29.12.m    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide;    or the compounds-   II-M.29.14a    1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine;-   II-M.29.14b    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol;-   II-M.29.16a    1-isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or-   II-M.29.16b 1-(1,2-dimethyl    propyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16c    N,5-dimethyl-N-pyridazin-4-yl-1-(2,2,2-trifluoro-1-methyl-ethyl)pyrazole-4-carboxamide;-   II-M.29.16d    1-[1-(1-cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16e    N-ethyl-1-(2-fluoro-1-methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16f    1-(1,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16g    1-[1-(1-cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16h    N-methyl-1-(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.16i    1-(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;    and-   II-M.29.16j    1-(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;-   II-M.29.17a    N-(1-methylethyl)-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17b N-cyclopropyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17c N-cyclohexyl-2-(3-pyridinyl)-2H-indazole-4-carboxamide;-   II-M.29.17d    2-(3-pyridinyl)-N-(2,2,2-trifluoroethyl)-2H-indazole-4-carboxamide;-   II-M.29.17e    2-(3-pyridinyl)-N-[(tetrahydro-2-furanyl)methyl]-2H-indazole-5-carboxamide;-   II-M.29.17f methyl    2-[[2-(3-pyridinyl)-2H-indazol-5-yl]carbonyl]hydrazinecarboxylate;-   II-M.29.17g    N-[(2,2-difluorocyclopropyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.17h    N-(2,2-difluoropropyl)-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.17i    2-(3-pyridinyl)-N-(2-pyrimidinylmethyl)-2H-indazole-5-carboxamide;    and-   II-M.29.17j    N-[(5-methyl-2-pyrazinyl)methyl]-2-(3-pyridinyl)-2H-indazole-5-carboxamide;-   II-M.29.18a    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfanyl)propanamide;-   II-M.29.18b    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-N-ethyl-3-(3,3,3-trifluoropropylsulfinyl)propanamide;-   II-M.29.18c    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfanyl]-N-ethyl-propanamide;    and-   II-M.29.18d    N-[3-chloro-1-(3-pyridyl)pyrazol-4-yl]-3-[(2,2-difluorocyclopropyl)methylsulfinyl]-N-ethyl-propanamide;-   II-M.29.19 sarolaner;-   II-M.29.20 lotilaner;-   II-L Biopesticides:-   II-L.1 Microbial pesticides with fungicidal, bactericidal, viricidal    and/or plant defense activator activity: Ampelomyces quisqualis,    Aspergillus flavus, Aureobasidium pullulans, Bacillus    altitudinis, B. amyloliquefaciens, B. megaterium, B. mojavensis, B.    mycoides, B. simplex, B. solisalsi, B. subtilis, B. subtilis var.    amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter    michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria    parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium    oxysporum, Clonostachys rosea f. catenulate (also named Gliocladium    catenulatum), Gliocladium roseum, Lysobacter antibioticus, L.    enzymogenes, Metschnikowia fructicola, Microdochium dimerum,    Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa,    Pantoea vagans, Penicillium bilaiae, Phlebiopsis gigantea,    Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa,    Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica,    Streptomyces griseoviridis, S. lydicus, S. violaceusniger,    Talaromyces flavus, T. asperellum, T. atroviride, T. fertile, T.    gamsii, T. harmatum, T. harzianum, T. polysporum, T. stromaticum, T.    virens, T. viride, Typhula phacorrhiza, Ulocladium oudemansii,    Verticillium dahlia, and zucchini yellow mosaic virus (avirulent    strain);-   II-L.2 Biochemical pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: harpin protein,    and Reynoutria sachalinensis extract;-   II-L.3 Microbial pesticides with insecticidal, acaricidal,    molluscidal and/or nematicidal activity: Agrobacterium radiobacter,    Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp.    aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp.    tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia spp.,    Chromobacterium subtsugae, Cydia pomonella granulovirus (CpGV),    Cryptophlebia leucotreta granulovirus (CrleGV), Flavobacterium spp.,    Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea    nucleopolyhedrovirus (HzNPV), Helicoverpa zea single capsid    nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, Isaria    fumosorosea, Lecanicillium longisporum, L. muscarium, Metarhizium    anisopliae, Metarhizium anisopliae var. anisopliae, M. anisopliae    var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P.    lilacinus, Paenibacillus popilliae, Pasteuria spp., P.    nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae,    Pseudomonas fluorescens, Spodoptera littoralis nucleopolyhedrovirus    (SpliNPV), Steinernema carpocapsae, S. feltiae, S. kraussei    Streptomyces galbus, and S. microflavus;-   II-L.4 Biochemical pesticides with insecticidal, acaricidal,    molluscidal, pheromone and/or nematicidal activity: L-carvone,    citral, (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate,    (E,Z)-2,4-ethyl decadienoate (pear ester),    (Z,Z,E)-7,11,13-hexadecatrienal, heptyl butyrate, isopropyl    myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1-butanol,    methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1-ol,    (E,Z)-2,13-octadecadien-1-ol acetate, (E,Z)-3,13-octadecadien-1-ol,    R-1-octen-3-ol, pentatermanone, (E,Z,Z)-3,8,11-tetradecatrienyl    acetate, (Z,E)-9,12-tetradecadien-1-yl acetate,    Z-7-tetradecen-2-one, Z-9-tetradecen-1-yl acetate,    Z-11-tetradecenal, Z-11-tetradecen-1-ol, extract of Chenopodium    ambrosiodes, Neem oil, and Quillay extract;-   II-L.5 Microbial pesticides with plant stress reducing, plant growth    regulator, plant growth promoting and/or yield enhancing    activity: A. lipoferum, A. irakense, A. halopraeferens, B. elkani B.    liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices,    Mesorhizobium spp., Rhizobium leguminosarum bv. phaseoli, R. l. bv.    trifolii, R. l. bv. viciae, R. tropici and Sinorhizobium meliloti;-   and/or at least one fungicidally active compound III selected from-   III-F.I Respiration inhibitors-   III-F.I1 Inhibitors of complex III at Q_(o) site: azoxystrobin,    coumethoxystrobin, coumoxystrobin, dimoxystrobin, enestroburin,    fenaminstrobin, fenoxystrobin/flufenoxystrobin, fluoxastrobin,    kresoxim-methyl, mandestrobin, metominostrobin, orysastrobin,    picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin,    trifloxystrobin,    2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide,    pyribencarb, triclopyricarb/chlorodincarb, famoxadone, and    fenamidone,    methyl-N-[2-[(1,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate,    1-[3-chloro-2-[[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-bromo-2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[1-(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyltetrazol-5-one,    1-[2-[[1-(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4-methyl-tetrazol-5-one,    1-[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-one,    1-[3-chloro-2-[[4-(p-tolyl)thiazol-2-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-cyclopropyl-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one,    1-[3-(difluoromethoxy)-2-[[2-methyl-4-(1-methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one,    1-methyl-4-[3-methyl-2-[[2-methyl-4-(1-methyl    pyrazol-3-yl)phenoxy]methyl]phenyl]tetrazol-5-one,    1-methyl-4-[3-methyl-2-[[1-[3-(trifluoromethyl)phenyl]-ethylideneamino]oxy-methyl]phenyl]tetrazol-5-one,    (Z,2E)-5-[1-(2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide,    (Z,2E)-5-[1-(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide,    and    (Z,2E)-5-[1-(4-chloro-2-fluoro-phenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethyl-pent-3-enamide;-   III-F.I2 inhibitors of complex III at Q_(i) site: cyazofamid,    amisulbrom,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxypyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate;    (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl    2-methylpropanoate, and    (3S,6S,7R,8R)-8-benzyl-3-[3-[(isobutyryloxy)methoxy]-4-methoxypicolinamido]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl    isobutyrate;-   III-F.I3 inhibitors of complex II: benodanil, benzovindiflupyr,    bixafen, boscalid, carboxin, fenfuram, fluopyram, flutolanil,    fluxapyroxad, furametpyr, isofetamid, isopyrazam, mepronil,    oxycarboxin, penflufen, penthiopyrad, sedaxane, tecloftalam,    thifluzamide,    N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,    N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3,5-trimethyl-N-(1,1,3-trimethyl    indan-4-yl)pyrazole-4-carboxamide,    N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide,    and    N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methyl-pyrazole-4-carboxamide;-   III-F.I4 other respiration inhibitors: diflumetorim,    (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine;    -   nitrophenyl derivates: binapacryl, dinobuton, dinocap,        fluazinam, ferimzone; organometal compounds: fentin-acetate,        fentin chloride, and fentin hydroxide; ametoctradin; and        silthiofam;-   III-F.II Sterol biosynthesis inhibitors:-   III-F.II1 C14 demethylase inhibitors:    -   triazoles: azaconazole, bitertanol, bromuconazole,        cyproconazole, difenoconazole, diniconazole, diniconazole-M,        epoxiconazole, fenbuconazole, fluquinconazole, flusilazole,        flutriafol, hexaconazole, imibenconazole, ipconazole,        metconazole, myclobutanil, oxpoconazole, paclobutrazole,        penconazole, propiconazole, prothioconazole, simeconazole,        tebuconazole, tetraconazole, triadimefon, triadimenol,        triticonazole, uniconazole,        1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazolo,        2-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,        1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,        2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,        2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,        2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pent-3-yn-2-ol;        imidazoles: imazalil, pefurazoate, prochloraz, triflumizol;    -   pyrimidines, pyridines and piperazines: fenarimol, nuarimol,        pyrifenox, triforine, and        [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;-   III-F.II2 Delta14-reductase inhibitors: aldimorph, dodemorph,    dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin,    piperalin, and spiroxamine;-   III-F.II3 Inhibitors of 3-keto reductase: fenhexamid;-   III-F.III Nucleic acid synthesis inhibitors-   IIIF.III1 phenylamides or acyl amino acid fungicides: benalaxyl,    benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace,    and oxadixyl;-   III-F.III2 others: hymexazole, octhilinone, oxolinic acid,    bupirimate, 5-fluorocytosine,    5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine, and    5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;-   III-F.IV Inhibitors of cell division and cytoskeleton-   III-F.IV1 tubulin inhibitors from the class of    -   benzimidazoles, and thiophanates: benomyl, carbendazim,        fuberidazole, thiabendazole, and thiophanatemethyl;    -   triazolopyrimidines:        5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)[1,2,4]triazolo[1,5-a]pyrimidine;        and-   III-F.IV2 other cell division inhibitors: diethofencarb, ethaboxam,    pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;-   III-F.V Inhibitors of amino acid and protein synthesis:-   III-F.V1 methionine synthesis inhibitors from the class of    anilino-pyrimidines: cyprodinil, mepanipyrim, and pyrimethanil; and-   III-F.V2 protein synthesis inhibitors: blasticidin-S, kasugamycin,    kasugamycin hydrochloridehydrate, mildiomycin, streptomycin,    oxytetracyclin, polyoxine, and validamycin A;-   III-F.VI Signal transduction inhibitors:-   III-F.VI1 MAP/histidine kinase inhibitors: fluoroimid, iprodione,    procymidone, vinclozolin, fenpiclonil, and fludioxonil; and-   III-F.VI2 G protein inhibitors: quinoxyfen;-   III-F.VII Lipid and membrane synthesis inhibitors:    -   F.VII1 Phospholipid biosynthesis inhibitors: edifenphos,        iprobenfos, pyrazophos, isoprothiolane;-   III-F.VII2 lipid peroxidation: dicloran, quintozene, tecnazene,    tolclofos-methyl, biphenyl, chloroneb, and etridiazole;-   III-F.VII3 phospholipid biosynthesis and cell wall deposition:    dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb,    iprovalicarb, valifenalate, and    N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic    acid-(4-fluorophenyl) ester;-   III-F.VII4 compounds affecting cell membrane permeability and fatty    acides: propamocarb; and-   III-F.VII5 fatty acid amide hydrolase inhibitors: oxathiapiprolin,    2-{3-[2-(1-{[3,5-bis(difluoromethyl-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl    methanesulfonate,    2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl),    and 1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl    methanesulfonate;-   III-F.VIII Inhibitors with Multi Site Action:-   III-F.VIII1 inorganic active substances: Bordeaux mixture, copper    acetate, copper hydroxide, copper oxychloride, basic copper sulfate,    and sulfur;-   III-F.VIII2 thio- and dithiocarbamates: ferbam, mancozeb, maneb,    metam, metiram, propineb, thiram, zineb, and ziram;-   III-F.VIII3 organochlorine compounds from the class of phthalimides,    sulfamides, and chloronitriles: anilazine, chlorothalonil, captafol,    captan, folpet, dichlofluanid, dichlorophen, hexachlorobenzene,    pentachlorphenole and its salts, phthalide, tolylfluanid, and    N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide; and-   III-F.VIII4 guanidines and others: guanidine, dodine, dodine free    base, guazatine, guazatineacetate, iminoctadine,    iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon,    and    2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)tetraone;-   III-F.IX Cell wall synthesis inhibitors:-   III-F.IX1 inhibitors of glucan synthesis: validamycin, and polyoxin    B;-   III-F.IX2 melanin synthesis inhibitors: pyroquilon, tricyclazole,    carpropamid, dicyclomet, and fenoxanil;-   III-F.X Plant defence inducers-   III-F.X1 acibenzolar-S-methyl, probenazole, isotianil, tiadinil,    prohexadione-calcium;-   III-F.X2 phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid    and its salts; potassium or sodium bicarbonate; and-   III-F.XI Unknown mode of action:    -   bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet,        debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate,        diphenylamin, fenpyrazamine, flumetover, flusulfamide,        flutianil, methasulfocarb, nitrapyrin, nitrothal-isopropyl,        oxathiapiprolin, tolprocarb, oxin-copper, proquinazid,        tebufloquin, tecloftalam, triazoxide,        2-butoxy-6-iodo-3-propylchromen-4-one,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,        N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl        acetamide,        N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl        formamidine,        N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl        formamidine, methoxy-acetic acid        6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl ester,        3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine,        3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine        (pyrisoxazole), N-(6-methoxy-pyridin-3-yl)        cyclopropanecarboxylic acid amide,        5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole,        2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide,        ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox,        pentyl        N-[6-[[(Z)-[(1-methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate,        2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol,        2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol,        3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,        and 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1,4-benzoxazepine;-   in a synergistically effective amount.

In a further embodiment of the invention there is provided seed,comprising the mixture of the invention in an amount of from 0.1 g to100 kg per 100 kg of seeds.

The invention provides for a pesticidal composition, comprising a liquidor solid carrier and a novel mixture according to the invention.

The simultaneous (that is joint or separate application of one or moreactive compound(s) I and one or more compound(s) II and/or III), orsuccessive application (that is immediately one after another andthereby creating the mixture “in-situ” on the desired location, as e.g.the plant, of one or more active compound(s) I and one or more activecompound(s) II and/or III) allows enhanced control of pests, inparticular Pentatomidae pests, and fungi compared to the control ratesthat are possible with the individual compounds.

The prior art does not disclose pesticidal mixtures for the control ofPentatomidae pests, particularly stink bugs, comprising such compounds Iin combination with the other pesticidically and/or fungicidally activecompounds.

The compound I of formula (I) includes its tautomers, racemic mixtures,individual pure enantiomers and diasteroemers and the optically activemixtures.

Preferred as compound I are bilobalide, ginkgolide A and a mixture ofbilobalide and ginkgolide A. Further preferred are mixtures comprisingbilobalide and/or ginkgolide A and at least one further compound I whichis different from bilobalide and ginkgolide A.

In one preferred embodiment compound (I) is bilobalide.

In another preferred embodiment compound (I) is ginkgolide A.

In another preferred embodiment compound (I) is ginkgolide B.

In another preferred embodiment compound (I) is ginkgolide C.

In another preferred embodiment compound (I) is ginkgolide I.

In another preferred embodiment compound (I) is ginkgolide M.

In another preferred embodiment compound (I) is a mixture of bilobalideand ginkgolide A.

In one preferred embodiment compound (I), preferably, bilobalide and/orginkgolide A, is mixed with one or more pesticidally compounds (II), inparticular preferred embodiments thereof, in particular the compoundslisted in Table A and the working examples.

In another preferred embodiment compound (I), preferably bilobalideand/or ginkgolide A, is mixed with one or more fungicidally activecompounds (III), in particular preferred embodiments thereof, inparticular the compounds listed in Table A and the working examples.

In another preferred embodiment compound (I), preferably bilobalideand/or ginkgolide A, is mixed with one or more pesticidally compounds(II), in particular preferred embodiments thereof, in particular thecompounds in Table 1 and the working examples, and with one or morefungicidally active compounds (III), in particular preferred embodimentsthereof, in particular the compounds listed in Table 1 and the workingexamples.

Bilobalide and the ginkgolides are known components of the ginkgo treehaving the following structures:

a) Bilobalide:

Bilobalide is the common name for(3aS,5aR,8aS,9R,10aR)-9-tert-butyl-8,9-dihydroxydihydro-9H-furo[2,3-b]furo[3′,2′;2,3]cyclopenta[1,2-c]furan-2,4,7(3H,8H)-trione(CAS 33570-04-6).

b) Ginkgolides:

Ginkgolide R¹ R² R³ CAS Ginkgolide A —H —OH —H 15291-75-5 Ginkgolide B—H —OH —OH 15291-77-7 Ginkgolide C —OH —OH —OH 15291-76-6 Ginkgolide J—OH —OH —H 15291-79-9 Ginkgolide M —OH —H —OH 15291-78-8

The above compounds can be used in pure form, as mixtures or in the formof extracts of ginkgo leaves, which may be enriched with the abovecompounds to a certain degree.

The compounds are commercially available, or can be obtained, preferablyfrom ginkgo leaves by methods known in the art and described e.g. inU.S. Pat. No. 5,700,468, EP-A 360 556, EP-A 0 431 535 and JP-A09-110713.

Further, the compounds Bilobalide (in enantiopure form), Ginkgolide A(in its racemic form) and Ginkgolide B (in its racemic form) can beobtained by chemical synthesis, as disclosed e.g. in Tetrahedron Letters(1988), 29(28), 3423-6, Tetrahedron Letters (1988), 29(26), 3205-6 andJournal of the American Chemical Society (2000), 122(35), 8453-8463,respectively.

Pesticidal Compounds II

The commercially available compounds of the group M listed above may befound in The Pesticide Manual, 16th Edition, C. MacBean, British CropProtection Council (2013) among other publications. The online PesticideManual is updated regularly and is accessible throughhttp://bcpcdata.com/pesticide-manual.html.

Another online data base for pesticides providing the ISO common namesis http://www.alanwood.net/pesticides.

The M.4 neonicotinoid cycloxaprid is known from WO2010/069266 andWO2011/069456, the neonicotinoid M.4A.2, sometimes also to be named asguadipyr, is known from WO2013/003977, and the neonicotinoid M.4A.3(approved as paichongding in China) is known from WO2007/101369. Themetaflumizone analogue M.22B.1 is described in CN10171577 and theanalogue M.22B.2 in CN102126994. The phthalamides M.28.1 and M.28.2 areboth known from WO2007/101540. The anthranilamide M.28.3 is described inWO2005/077934. The hydrazide compound M.28.4 is described inWO2007/043677. The anthranilamides M.28.5a) to M.28.5d) and M.28.5h) aredescribed in WO 2007/006670, WO2013/024009 and WO2013/024010, theanthranilamide M.28.5i) is described in WO2011/085575, M.28.5j) inWO2008/134969, M.28.5k) in US2011/046186 and M.28.5l) in WO2012/034403.The diamide compound M.28.6 can be found in WO2012/034472. Thespiroketal-substituted cyclic ketoenol derivative M.29.3 is known fromWO2006/089633 and the biphenyl-substituted spirocyclic ketoenolderivative M.29.4 from WO2008/067911. The triazoylphenylsulfide M.29.5is described in WO2006/043635, and biological control agents on thebasis of Bacillus firmus are described in WO2009/124707. The compoundsM.29.6a) to M.29.6i) listed under M.29.6 are described in WO2012/029672,and M.29.6j) and M.29.6k) in WO2013/129688. The nematicide M.29.8 isknown from WO2013/055584. The isoxazoline M.29.9.a) is described inWO2013/050317. The isoxazoline M.29.9.b) is described in WO2014/126208.The pyridalyl-type analogue M.29.10 is known from WO2010/060379. Thecarboxamides broflanilide and M.29.11.b) to M.29.11.h) are described inWO2010/018714, and the carboxamides M.29.11i) to M.29.11.p) inWO2010/127926. The pyridylthiazoles M.29.12.a) to M.29.12.c) are knownfrom WO2010/006713, M.29.12.d) and M.29.12.e) are known fromWO2012/000896, and M.29.12.f) to M.29.12.m) from WO2010/129497. Thecompounds M.29.14a) and M.29.14b) are known from WO2007/101369. Thepyrazoles M.29.16.a) to M.29.16h) are described in WO2010/034737,WO2012/084670, and WO2012/143317, respectively, and the pyrazolesM.29.16i) and M.29.16j) are described in U.S. 61/891,437. Thepyridinylindazoles M.29.17a) to M.29.17.j) are described inWO2015/038503. The pyridylpyrazoles M.29.18a) to M.29.18d) are describedin US2014/0213448. The isoxazoline M.29.19 is described inWO2014/036056. The isoxazoline M.29.20 is known from WO2014/090918.

The biopesticides of group II-L are disclosed further below in theparagraphs about biopesticides II-L).

Fungicidal Compounds III

The fungicides described by common names, their preparation and theiractivity e.g. against harmful fungi is known (cf.:http://www.alanwood.net/pesticides/); these substances are commerciallyavailable.

The fungicides described by IUPAC nomenclature, their preparation andtheir pesticidal activity is also known (cf. Can. J. Plant Sci. 48(6),587-94, 1968; EP-A 141 317; EP-A 152 031; EP-A 226 917; EP-A 243 970;EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE10021412; DE 102005009458; U.S. Pat. Nos. 3,296,272; 3,325,503; WO98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO07/82098; WO 07/90624, WO 11/028657, WO2012/168188, WO 2007/006670, WO2011/77514; WO13/047749, WO 10/069882, WO 13/047441, WO 03/16303, WO09/90181, WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO13/024010 and WO 13/047441, WO 13/162072, WO 13/092224, WO 11/135833).

Biopesticides

The biopesticides from their preparation and their pesticidal activitye.g. against harmful fungi or insects are known (e-Pesticide Manual V5.2 (ISBN 978 1 901396 85 0) (2008-2011);http://www.epa.gov/opp00001/biopesticides/, see product lists therein;http://www.omri.org/omrilists, see lists therein; Bio-PesticidesDatabase BPDB http://sitem.herts.ac.uk/aeru/bpdb/, see A to Z linktherein).

The biopesticides may also have insecticidal, fungicidal, acaricidal,molluscidal, viricidal, bactericidal, pheromone, nematicidal, plantdefense activator, plant stress reducing, plant growth regulator, plantgrowth promoting, plant growth regulator and/or yield enhancingactivity.

Many of these biopesticides are registered and/or are commerciallyavailable. E.g. Beauveria bassiana ATCC 74040 (e.g. in Naturalis® fromCBC (Europe) S.r.l., Italy), B. bassiana DSM 12256 (US 200020031495;e.g. BioExpert® SC from Live Sytems Technology S.A., Colombia), B.bassiana GHA (BotaniGard® 22WGP from Laverlam Int. Corp., USA), and B.bassiana PPRI 5339 (ARSEF number 5339 in the USDA ARS collection ofentomopathogenic fungal cultures; NRRL 50757) (e.g. BroadBand® fromBecker Underwood, South Africa).

PREFERRED EMBODIMENTS

In one preferred embodiment of the method of the invention the at leastone pesticidally active compound II is selected from group M consistingof

-   II-M.1 Acetylcholine esterase (AChE) inhibitors from the class of-   II-M.1A carbamates, for example aldicarb, alanycarb, bendiocarb,    benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran,    carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb,    isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb,    propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and    triazamate; or from the class of-   M.1B organophosphates, for example acephate, azamethiphos,    azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos,    chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl,    coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/DDVP,    dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion,    ethoprophos, famphur, fenamiphos, fenitrothion, fenthion,    fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl    O-(methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion,    mecarbam, methamidophos, methidathion, mevinphos, monocrotophos,    naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl,    phenthoate, phorate, phosalone, phosmet, phosphamidon, phoxim,    pirimiphos-methyl, profenofos, propetamphos, prothiofos, pyraclofos,    pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos,    terbufos, tetrachlorvinphos, thiometon, triazophos, trichlorfon and    vamidothion;-   II-M.2 GABA-gated chloride channel antagonists such as:-   II-M.2A cyclodiene organochlorine compounds, as for example    endosulfan or chlordane; or-   II-M.2B fiproles (phenylpyrazoles), as for example ethiprole,    fipronil, flufiprole, pyrafluprole and pyriprole;-   M.3 Sodium channel modulators from the class of-   M.3A pyrethroids, for example acrinathrin, allethrin, d-cis-trans    allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin    S-cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin,    beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin,    cypermethrin, alpha-cypermethrin, beta-cypermethrin,    theta-cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin,    empenthrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate,    flucythrinate, flumethrin, tau-fluvalinate, halfenprox,    heptafluthrin, imiprothrin, meperfluthrin, metofluthrin,    momfluorothrin, permethrin, phenothrin, prallethrin, profluthrin,    pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin,    tetramethylfluthrin, tetramethrin, tralomethrin and transfluthrin;    or-   M.3B sodium channel modulators such as DDT or methoxychlor;-   II-M.4 Nicotinic acetylcholine receptor agonists (nAChR) from the    class of-   II-M.4A neonicotinoids, for example acetamiprid, chlothianidin,    cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid and    thiamethoxam; or the compounds-   II-M.4A.2:    (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide;    or-   II-M.4A.3:    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine;    or from the class-   II-M.4B nicotine;-   II-M.5 Nicotinic acetylcholine receptor allosteric activators from    the class of spinosyns, for example spinosad or spinetoram;-   II-M.6 Chloride channel activators from the class of avermectins and    milbemycins, for example abamectin, emamectin benzoate, ivermectin,    lepimectin or milbemectin;-   II-M.7 Juvenile hormone mimics, such as-   II-M.7A juvenile hormone analogues as hydroprene, kinoprene and    methoprene; or others as-   II-M.7B fenoxycarb, or-   II-M.7C pyriproxyfen;-   II-M.8 miscellaneous non-specific (multi-site) inhibitors, for    example-   II-M.8A alkyl halides as methyl bromide and other alkyl halides, or-   II-M.8B chloropicrin, or-   II-M.8C sulfuryl fluoride, or-   II-M.8D borax, or-   II-M.8E tartar emetic;-   II-M.9 Selective homopteran feeding blockers, for example-   II-M.9B pymetrozine, or-   II-M.9C flonicamid;-   II-M.10 Mite growth inhibitors, including-   II-M.10A clofentezine, hexythiazox and diflovidazin, or-   II-M.10B etoxazole;-   II-M.11 Microbial disruptors of insect midgut membranes, for example    Bacillus thuringiensis or Bacillus sphaericus and the insecticdal    proteins they produce such as Bacillus thuringiensis subsp.    israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp.    aizawai and Bacillus thuringiensis subsp. tenebrionis, or the Bt    crop proteins: Cry1Ab, Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab,    Cry3Bb and Cry34/35Ab1;-   II-M.12 Inhibitors of mitochondrial ATP synthase, for example-   II-M.12A diafenthiuron, or-   II-M.12B organotin miticides such as azocyclotin, cyhexatin or    fenbutatin oxide, or-   II-M.12C propargite, or-   II-M.12D tetradifon;-   II-M.13 Uncouplers of oxidative phosphorylation via disruption of    the proton gradient, for example chlorfenapyr, DNOC or sulfluramid;-   II-M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers,    for example nereistoxin analogues as bensultap, cartap    hydrochloride, thiocyclam or thiosultap sodium;-   II-M.15 Inhibitors of the chitin biosynthesis type 0, such as    benzoylureas as for example bistrifluron, chlorfluazuron,    diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron,    novaluron, noviflumuron, teflubenzuron or triflumuron;-   II-M.16 Inhibitors of the chitin biosynthesis type 1, as for example    buprofezin;-   II-M.17 Moulting disruptors, Dipteran, as for example cyromazine;-   II-M.18 Ecdyson receptor agonists such as diacylhydrazines, for    example methoxyfenozide, tebufenozide, halofenozide, fufenozide or    chromafenozide;-   II-M.19 Octopamin receptor agonists, as for example amitraz;-   II-M.20 Mitochondrial complex III electron transport inhibitors, for    example-   II-M.20A hydramethylnon, or-   II-M.20B acequinocyl, or-   II-M.20C fluacrypyrim;-   II-M.21 Mitochondrial complex I electron transport inhibitors, for    example-   II-M.21A METI acaricides and insecticides such as fenazaquin,    fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad or tolfenpyrad,    or-   II-M.21B rotenone;-   II-M.22 Voltage-dependent sodium channel blockers, for example-   II-M.22A indoxacarb, or-   II-M.22B metaflumizone, or-   II-M.22B.1:    2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide    or-   II-M.22B.2:    N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;-   II-M.23 Inhibitors of the of acetyl CoA carboxylase, such as    tetronic and tetramic acid derivatives, for example spirodiclofen,    spiromesifen or spirotetramat;-   II-M.24 Mitochondrial complex IV electron transport inhibitors, for    example-   II-M.24A phosphine such as aluminium phosphide, calcium phosphide,    phosphine or zinc phosphide, or-   II-M.24B cyanide;-   II-M.25 Mitochondrial complex II electron transport inhibitors, such    as beta-ketonitrile derivatives, for example cyenopyrafen or    cyflumetofen;-   II-M.28 Ryanodine receptor-modulators from the class of diamides, as    for example flubendiamide, chlorantraniliprole (Rynaxypyr®),    cyantraniliprole (Cyazypyr®), or the phthalamide compounds-   II-M.28.1:    (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid    and-   II-M.28.2:    (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid,    or the compound-   II-M.28.3:    3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide    (proposed ISO name: cyclaniliprole), or the compound-   II-M.28.4:    methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate;-   or a compound selected from M.28.5a) to M.28.5l):-   II-M.28.5a)    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5b)    N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5c)    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5d)    N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5e)    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5f)    N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5g)    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5h)    N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5i)    N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5j)    3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide;-   II-M.28.5k)    3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5l)    N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide;-   or a compound selected from-   II-M.28.6:    N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-3-iodobenzene-1,2-dicarboxamide;    or-   II-M.28.7:    3-Chloro-N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-benzene-1,2-dicarboxamide;-   II-M.28.8a)    1-(3-Chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-[[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl]-1H-pyrazole-5-carboxamide    (proposed ISO name: tetraniliprole); or-   II-M.28.8b)    1-(3-Chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-[[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl]-1H-pyrazole-5-carboxamide;-   II-M.UN Insecticidally active compounds of unknown or uncertain mode    of action, as for example afidopyropen, afoxolaner, azadirachtin,    amidoflumet, benzoximate, bifenazate, bromopropylate,    chinomethionat, cryolite, dicofol, flufenerim, flometoquin,    fluensulfone, fluopyram, flupyradifurone, fluralaner, metoxadiazone,    piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon,    sulfoxaflor, tioxazafen, triflumezopyrim, or the compounds-   II-M.UN.3:    11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one,    or the compound-   II-M.UN.4:    3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one,    or the compound-   II-M.UN.5:    1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine;    or a compound selected from the group of M.UN.6, wherein the    compound is selected from M.UN.6a) to M.UN.6k):-   II-M.UN.6a)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6b)    (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6c)    (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide;-   II-M.UN.6d)    (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6e)    (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6f)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.UN.6g)    (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.UN.6h)    (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6i)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoropropanamide.);-   II-M.UN.6j)    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide    or of the compound-   II-M.UN.6k)    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine    or the compounds-   II-M.UN.8:    8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide;    or-   II-M.UN.9:    4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide;    or-   II-M.UN.10:    5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole;    or a compound selected from the group of M.UN.12, wherein the    compound is selected from M.UN.12a) to M.UN.12m):-   II-M.UN.12.a)    2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine;-   II-M.UN.12.b)    2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.UN.12.c)    2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.UN.12.d) N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide-   II-M.UN.12.e) N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide-   II-M.UN.12.f)    N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.g)    N-Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.h)    N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.i)    N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.j)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide-   II-M.UN.12.k)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide-   II-M.UN.12.l)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide-   II-M.UN.12.m)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide;    or the compound-   II-M.UN.13:    2-(4-methoxyiminocyclohexyl)-2-(3,3,3-trifluoropropylsulfonyl)acetonitrile;    or the compounds-   II-M.UN.14a)    1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine;    or-   II-M.UN.14b)    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol;    or the compound-   II-M.UN.15:    1-[(2-Chloro-1,3-thiazol-5-yl)methyl]-3-(3,5-dichlorophenyl)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate;    or-   II-M.BP Biopesticides, being pesticidal compounds of biological    origin with insecticidal, acaricidal, molluscidal and/or nematicidal    activity, including-   II-M.BP-1: Microbial pesticides: Bacillus firmus, B. thuringiensis    ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki,    Beauveria bassiana, Burkholderia sp., Chromobacterium subtsugae,    Cydia pomonella granulosis virus, Isaria fumosorosea, Lecanicillium    longisporum, L. muscarium (formerly Verticillium lecanii),    Metarhizium anisopliae, M. anisopliae var. acridum, Paecilomyces    fumosoroseus, P. lilacinus, Paenibacillus poppiliae, Pasteuria    spp., P. nishizawae, P. reneformis, P. usagae, Pseudomonas    fluorescens, Steinernema feltiae, Streptomces galbus; or-   II-M.BP-2: Biochemical pesticides: L-carvone, citral,    (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate, (E,Z)-2,4-ethyl    decadienoate (pear ester), (Z,Z,E)-7,11,13-hexadecatrienal, heptyl    butyrate, isopropyl myristate, lavanulyl senecioate, 2-methyl    1-butanol, methyl eugenol, methyl jasmonate,    (E,Z)-2,13-octadecadien-1-ol, (E,Z)-2,13-octadecadien-1-ol acetate,    (E,Z)-3,13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone,    potassium silicate, sorbitol actanoate,    (E,Z,Z)-3,8,11-tetradecatrienyl acetate,    (Z,E)-9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-one,    Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal,    Z-11-tetradecen-1-ol, Acacia negra extract, extract of grapefruit    seeds and pulp, extract of Chenopodium ambrosiodae, Catnip oil, Neem    oil, Quillay extract, Tagetes oil,-   and/or-   the at least one fungicidally active compound III is selected from    group F consisting of:-   F.I) Respiration inhibitors-   F.I 1) Inhibitors of complex III at Q_(o) site (e.g. strobilurins):    azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin,    enestroburin, fenaminstrobin, fenoxystrobin/flufenoxystrobin,    fluoxastrobin, kresoxim-methyl, mandestrobine, metominostrobin,    orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin,    pyraoxystrobin, trifloxystrobin and    2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide,    pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;-   F.I 2) inhibitors of complex III at Q_(i) site: cyazofamid,    amisulbrom,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate;    (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl    2-methylpropanoate;-   F.I 3) inhibitors of complex II (e. g. carboxamides): benodanil,    benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram,    flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam,    mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane,    tecloftalam, thifluzamide,    N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,    N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide,    N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide,    N-[2-(2,4-difluorophenyl)phenyl]-3-(trifluoromethyl)pyrazine-2-carboxamide;-   F.I 4) other respiration inhibitors (e.g. complex I, uncouplers):    diflumetorim,    (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine;    nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam;    ferimzone; organometal compounds: fentin salts, such as    fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin;    and silthiofam;-   F.II) Sterol biosynthesis inhibitors (SBI fungicides)-   F.II 1) C14 demethylase inhibitors (DMI fungicides): triazoles:    azaconazole, bitertanol, bromuconazole, cyproconazole,    difenoconazole, diniconazole, diniconazole-M, epoxiconazole,    fenbuconazole, fluquinconazole, flusilazole, flutriafol,    hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil,    oxpoconazole, paclobutrazole, penconazole, propiconazole,    prothioconazole, simeconazole, tebuconazole, tetraconazole,    triadimefon, triadimenol, triticonazole, uniconazole,    1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H[1,2,4]triazole,    2-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,    1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,    2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol;    imidazoles: imazalil, pefurazoate, prochloraz, triflumizol;    pyrimidines, pyridines and piperazines: fenarimol, nuarimol,    pyrifenox, triforine,    [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;-   F.II 2) Delta14-reductase inhibitors: aldimorph, dodemorph,    dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin,    piperalin, spiroxamine;-   F.II 3) Inhibitors of 3-keto reductase: fenhexamid;-   F.III) Nucleic acid synthesis inhibitors-   F.III 1) phenylamides or acyl amino acid fungicides: benalaxyl,    benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace,    oxadixyl;-   F.III 2) others: hymexazole, octhilinone, oxolinic acid, bupirimate,    5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine,    5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;-   F.IV) Inhibitors of cell division and cytoskeleton-   F.IV 1) tubulin inhibitors, such as benzimidazoles, thiophanates:    benomyl, carbendazim, fuberidazole, thiabendazole,    thiophanate-methyl; triazolopyrimidines:    5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine;-   F.IV 2) other cell division inhibitors: diethofencarb, ethaboxam,    pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;-   F.V) Inhibitors of amino acid and protein synthesis-   F.V 1) methionine synthesis inhibitors (anilino-pyrimidines):    cyprodinil, mepanipyrim, pyrimethanil;-   F.V 2) protein synthesis inhibitors: blasticidin-S, kasugamycin,    kasugamycin hydrochloridehydrate, mildiomycin, streptomycin,    oxytetracyclin, polyoxine, validamycin A;-   F.VI) Signal transduction inhibitors-   F.VI 1) MAP/histidine kinase inhibitors: fluoroimid, iprodione,    procymidone, vinclozolin, fenpiclonil, fludioxonil;-   F.VI 2) G protein inhibitors: quinoxyfen;-   F.VII) Lipid and membrane synthesis inhibitors-   F.VII 1) Phospholipid biosynthesis inhibitors: edifenphos,    iprobenfos, pyrazophos, isoprothiolane;-   F.VII 2) lipid peroxidation: dicloran, quintozene, tecnazene,    tolclofos-methyl, biphenyl, chloroneb, etridiazole;-   F.VII 3) phospholipid biosynthesis and cell wall deposition:    dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb,    iprovalicarb, valifenalate and    N-(1-(1-(4-cyanophenyl)ethanesulfonyl)-but-2-yl) carbamic    acid-(4-fluorophenyl) ester;-   F.VII 4) compounds affecting cell membrane permeability and fatty    acides: propamocarb, propamocarb-hydrochlorid;-   F.VII 5) fatty acid amide hydrolase inhibitors: oxathiapiprolin;-   F.VIII) Inhibitors with Multi Site Action-   F.VIII 1) inorganic active substances: Bordeaux mixture, copper    acetate, copper hydroxide, copper oxychloride, basic copper sulfate,    sulfur;-   F.VIII 2) thio- and dithiocarbamates: ferbam, mancozeb, maneb,    metam, metiram, propineb, thiram, zineb, ziram;-   F.VIII 3) organochlorine compounds (e.g. phthalimides, sulfamides,    chloronitriles): anilazine, chlorothalonil, captafol, captan,    folpet, dichlofluanid, dichlorophen, hexachlorobenzene,    pentachlorphenole and its salts, phthalide, tolylfluanid,    N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;-   F.VIII 4) guanidines and others: guanidine, dodine, dodine free    base, guazatine, guazatineacetate, iminoctadine,    iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon,    2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone;-   F.IX) Cell wall synthesis inhibitors-   F.IX 1) inhibitors of glucan synthesis: validamycin, polyoxin B;-   F.IX 2) melanin synthesis inhibitors: pyroquilon, tricyclazole,    carpropamid, dicyclomet, fenoxanil;-   F.X) Plant defence inducers-   F.X 1) acibenzolar-S-methyl, probenazole, isotianil, tiadinil,    prohexadione-calcium;-   F.X 2) phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and    its salts,    4-cyclopropyl-N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide;-   F.XI) Unknown mode of action-   bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet,    debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate,    diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil,    methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin,    picarbutrazox, tolprocarb,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide,    2-butoxy-6-iodo-3-propylchromen-4-one,    N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl    acetamide,    N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl    formamidine, methoxy-acetic acid    6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester,    3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine,    3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine    (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic    acid amide,    5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole,    2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide,    ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, pentyl    N-[6-[[(Z)-[(1-methyltetrazol-5-yl)phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate,    2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol,    2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol,    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,    3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,    3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline;-   F.XII) Biopesticides-   F.XII 1) Microbial pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: Ampelomyces    quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus    amyloliquefaciens, B. mojavensis, B. simplex, B. solisalsi, B.    subtilis, B. subtilis var. amyloliquefaciens, Candida oleophila, C.    saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium    minitans, Cryphonectria parasitica, Cryptococcus albidus,    Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f.    catenulate (also named Gliocladium catenulatum), Gliocladium roseum,    Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicola,    Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus,    Paenibacillus polymyxa, Pantoea vagans, Phlebiopsis gigantea,    Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa,    Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica,    Streptomyces griseoviridis, S. lydicus, S. violaceusniger,    Talaromyces flavus, Trichoderma atroviride, T. fertile, T.    gamsii, T. harmatum, T. harzianum; mixture of T. harzianum and T.    viride; mixture of T. polysporum and T. harzianum; T.    stromaticum, T. virens (also named Gliocladium virens), T. viride,    Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia,    zucchini yellow mosaic virus (avirulent strain);-   F.XII 2) Biochemical pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: chitosan    (hydrolysate), harpin protein, laminarin, Menhaden fish oil,    natamycin, Plum pox virus coat protein, potassium or sodium    bicarbonate, Reynoutria sachlinensis extract, salicylic acid, tea    tree oil

In one preferred embodiment of the mixtures of the invention compoundsII and/or III are selected from:

-   III-M.1 Acetylcholine esterase (AChE) inhibitors from the class of-   II-M.1A carbamates, for example aldicarb, alanycarb, bendiocarb,    benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran,    carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb,    isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb,    propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and    triazamate; or from the class of-   II-M.2 GABA-gated chloride channel antagonists such as:-   II-M.2A cyclodiene organochlorine compounds, as for example    endosulfan or chlordane; or-   II-M.2B fiproles (phenylpyrazoles), as for example ethiprole,    fipronil, flufiprole, pyrafluprole and pyriprole;-   II-M.3 Sodium channel modulators selected from sodium channel    modulators such as DDT or methoxychlor;-   II-M.4 Nicotinic acetylcholine receptor agonists (nAChR) from the    class of-   II-M.4A neonicotinoids, for example acetamiprid, chlothianidin,    cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thiacloprid and    thiamethoxam; or the compounds-   II-M.4A.2:    (2E-)-1-[(6-Chloropyridin-3-yl)methyl]-N′-nitro-2-pentylidenehydrazinecarboximidamide;    or-   II-M4A.3:    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-5-propoxy-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine;    or from the class-   II-M.4B nicotine;-   II-M.5 Nicotinic acetylcholine receptor allosteric activators from    the class of spinosyns, for example spinosad or spinetoram;-   II-M.6 Chloride channel activators from the class of avermectins and    milbemycins, for example abamectin, emamectin benzoate, ivermectin,    lepimectin or milbemectin;-   II-M.7 Juvenile hormone mimics, such as-   II-M.7A juvenile hormone analogues as hydroprene, kinoprene and    methoprene; or others as-   II-M.7B fenoxycarb, or-   II-M.7C pyriproxyfen;-   II-M.8 miscellaneous non-specific (multi-site) inhibitors, for    example-   II-M.8A alkyl halides as methyl bromide and other alkyl halides, or-   II-M.8B chloropicrin, or-   II-M.8C sulfuryl fluoride, or-   II-M.8D borax, or-   II-M.8E tartar emetic;-   II-M.9 Selective homopteran feeding blockers, for example-   II-M.9B pymetrozine, or-   II-M.9C flonicamid;-   II-M.10 Mite growth inhibitors, including-   II-M.10A clofentezine, hexythiazox and diflovidazin, or-   II-M.10B etoxazole;-   II-M.11 Microbial disruptors of insect midgut membranes, for example    Bacillus thuringiensis or Bacillus sphaericus and the insecticdal    proteins they produce such as Bacillus thuringiensis subsp.    israelensis, Bacillus sphaericus, Bacillus thuringiensis subsp.    aizawai, bacillus thuringiensis subsp. kurstaki and Bacillus    thuringiensis subsp. tenebrionis, or the Bt crop proteins: Cry1Ab,    Cry1Ac, Cry1Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1;-   II-M.12 Inhibitors of mitochondrial ATP synthase, for example-   II-M.12A diafenthiuron, or-   II-M.12B organotin miticides such as azocyclotin, cyhexatin or    fenbutatin oxide, or-   II-M.12C propargite, or-   II-M.12D tetradifon;-   II-M.13 Uncouplers of oxidative phosphorylation via disruption of    the proton gradient, for example chlorfenapyr, DNOC or sulfluramid;-   II-M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers,    for example nereistoxin analogues as bensultap, cartap    hydrochloride, thiocyclam or thiosultap sodium;-   II-M.15 Inhibitors of the chitin biosynthesis type 0, such as    benzoylureas as for example bistrifluron, chlorfluazuron,    diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron,    novaluron, noviflumuron, teflubenzuron or triflumuron;-   II-M.16 Inhibitors of the chitin biosynthesis type 1, as for example    buprofezin;-   II-M.17 Moulting disruptors, Dipteran, as for example cyromazine;-   II-M.18 Ecdyson receptor agonists such as diacylhydrazines, for    example methoxyfenozide, tebufenozide, halofenozide, fufenozide or    chromafenozide;-   II-M.19 Octopamin receptor agonists, as for example amitraz;-   II-M.20 Mitochondrial complex III electron transport inhibitors, for    example-   II-M.20A hydramethylnon, or-   II-M.20B acequinocyl, or-   II-M.20C fluacrypyrim;-   II-M.21 Mitochondrial complex I electron transport inhibitors, for    example-   II-M.21A METI acaricides and insecticides such as fenazaquin,    fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad or tolfenpyrad,    or-   II-M.21B rotenone;-   II-M.22 Voltage-dependent sodium channel blockers, for example-   II-M.22A indoxacarb, or-   II-M.22B metaflumizone, or-   II-M.22B.1:    2-[2-(4-Cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide    or-   II-M.22B.2:    N-(3-Chloro-2-methylphenyl)-2-[(4-chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;-   II-M.23 Inhibitors of the of acetyl CoA carboxylase, such as    tetronic and tetramic acid derivatives, for example spirodiclofen,    spiromesifen or spirotetramat;-   II-M.24 Mitochondrial complex IV electron transport inhibitors, for    example-   II-M.24A phosphine such as aluminium phosphide, calcium phosphide,    phosphine or zinc phosphide, or-   II-M.24B cyanide;-   II-M.25 Mitochondrial complex II electron transport inhibitors, such    as beta-ketonitrile derivatives, for example cyenopyrafen or    cyflumetofen;-   II-M.28 Ryanodine receptor-modulators from the class of diamides, as    for example flubendiamide, chlorantraniliprole (Rynaxypyr®),    cyantraniliprole (Cyazypyr®), or the phthalamide compounds-   II-M.28.1:    (R)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid    and-   II-M.28.2:    (S)-3-Chlor-N1-{2-methyl-4-[1,2,2,2-tetrafluor-1-(trifluormethyl)ethyl]phenyl}-N2-(1-methyl-2-methylsulfonylethyl)phthalamid,    or the compound-   II-M.28.3:    3-bromo-N-{2-bromo-4-chloro-6-[(1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chlorpyridin-2-yl)-1H-pyrazole-5-carboxamide    (proposed ISO name: cyclaniliprole), or the compound-   II-M.28.4:    methyl-2-[3,5-dibromo-2-({[3-bromo-1-(3-chlorpyridin-2-yl)-1H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1,2-dimethylhydrazinecarboxylate;-   or a compound selected from M.28.5a) to M.28.5l):-   II-M.28.5a)    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5b)    N-[4-chloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5c)    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5d)    N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5e)    N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(difluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5f)    N-[4,6-dibromo-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5g)    N-[4-chloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]-6-cyano-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5h)    N-[4,6-dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide;-   II-M.28.5i)    N-[2-(5-Amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridinyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5j)    3-Chloro-1-(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1-cyano-1-methylethyl)amino]carbonyl]phenyl]-1H-pyrazole-5-carboxamide;-   II-M.28.5k)    3-Bromo-N-[2,4-dichloro-6-(methylcarbamoyl)phenyl]-1-(3,5-dichloro-2-pyridyl)-1H-pyrazole-5-carboxamide;-   II-M.28.5l)    N-[4-Chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridinyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide;-   or a compound selected from-   II-M.28.6:    N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-3-iodobenzene-1,2-dicarboxamide;    or-   II-M.28.7:    3-Chloro-N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-benzene-1,2-dicarboxamide;-   II-M.28.8a)    1-(3-Chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-[[5-(trifluoromethyl)-2H-tetrazol-2-yl]methyl]-1H-pyrazole-5-carboxamide;    or-   II-M.28.8b)    1-(3-Chloro-2-pyridinyl)-N-[4-cyano-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-[[5-(trifluoromethyl)-1H-tetrazol-1-yl]methyl]-1H-pyrazole-5-carboxamide;-   II-M.UN Insecticidally active compounds of unknown or uncertain mode    of action, as for example afidopyropen, afoxolaner, azadirachtin,    amidoflumet, benzoximate, bifenazate, bromopropylate,    chinomethionat, cryolite, dicofol, flufenerim, flometoquin,    fluensulfone, fluopyram, flupyradifurone, fluralaner, metoxadiazone,    piperonyl butoxide, pyflubumide, pyridalyl, pyrifluquinazon,    sulfoxaflor, tioxazafen, triflumezopyrim, or the compounds-   II-M.UN.3:    11-(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1,4-dioxa-9-azadispiro[4.2.4.2]-tetradec-11-en-10-one,    or the compound-   II-M.UN.4:    3-(4′-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1-azaspiro[4.5]dec-3-en-2-one,    or the compound-   II-M.UN.5:    1-[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1H-1,2,4-triazole-5-amine;    or a compound selected from the group of M.UN.6, wherein the    compound is selected from II-II-M.UN.6a) to M.UN.6k):-   II-M.UN.6a)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6b)    (E/Z)-N-[1-[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6c)    (E/Z)-2,2,2-trifluoro-N-[1-[(6-fluoro-3-pyridyl)methyl]-2-pyridylidene]acetamide;-   II-M.UN.6d)    (E/Z)-N-[1-[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6e)    (E/Z)-N-[1-[1-(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6f)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.UN.6g)    (E/Z)-2-chloro-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro-acetamide;-   II-M.UN.6h)    (E/Z)-N-[1-[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro-acetamide;-   II-M.UN.6i)    (E/Z)-N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoropropanamide.);-   II-M.UN.6j)    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-thioacetamide    or of the compound-   II-M.UN.6k)    N-[1-[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N′-isopropyl-acetamidine    or the compounds-   II-M.UN.8:    8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1,2-a]pyridine-2-carboxamide;    or-   II-M.UN.9:    4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1-oxothietan-3-yl)benzamide;    or-   II-M.UN.10:    5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1H-pyrazole;    or a compound selected from the group of M.UN.12, wherein the    compound is selected from M.UN.12a) to M.UN.12m):-   II-M.UN.12.a)    2-(1,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine;-   II-M.UN.12.b)    2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.UN.12.c)    2-[6-[2-(3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine;-   II-M.UN.12.d) N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide-   II-M.UN.12.e) N-M    ethylsulfonyl-6-[2-(3-pyridyl)thiazol-5-yl]pyridine-2-carboxamide-   II-M.UN.12.f)    N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.g) N-M    ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.h)    N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.i)    N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3-methylthio-propanamide-   II-M.UN.12.j)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3-methylthio-propanamide-   II-M.UN.12.k)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3-methylthio-propanamide-   II-M.UN.12.l)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio-propanamide-   II-M.UN.12.m)    N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio-propanamide;    or the compound-   II-M.UN.13:    2-(4-methoxyiminocyclohexyl)-2-(3,3,3-trifluoropropylsulfonyl)acetonitrile;    or the compounds-   II-M.UN.14a)    1-[(6-Chloro-3-pyridinyl)methyl]-1,2,3,5,6,7-hexahydro-5-methoxy-7-methyl-8-nitro-imidazo[1,2-a]pyridine;    or-   II-M.UN.14b)    1-[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridin-5-ol;    or the compound-   II-M.UN.15:1-[(2-Chloro-1,3-thiazol-5-yl)methyl]-3-(3,5-dichlorophenyl)-9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-1-ium-2-olate;    or-   II-M.BP Biopesticides, being pesticidal compounds of biological    origin with insecticidal, acaricidal, molluscidal and/or nematicidal    activity, including-   II-M.BP-1: Microbial pesticides: Bacillus firmus, B. thuringiensis    ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki,    Beauveria bassiana, Burkholderia sp., Chromobacterium subtsugae,    Cydia pomonella granulosis virus, Isaria fumosorosea, Lecanicillium    longisporum, L. muscarium (formerly Verticillium lecanii),    Metarhizium anisopliae, M. anisopliae var. acridum, Paecilomyces    fumosoroseus, P. lilacinus, Paenibacillus poppiliae, Pasteuria    spp., P. nishizawae, P. reneformis, P. usagae, Pseudomonas    fluorescens, Steinernema feltiae, Streptomces galbus; or-   II-M.BP-2: Biochemical pesticides: L-carvone, citral,    (E,Z)-7,9-dodecadien-1-yl acetate, ethyl formate, (E,Z)-2,4-ethyl    decadienoate (pear ester), (Z,Z,E)-7,11,13-hexadecatrienal, heptyl    butyrate, isopropyl myristate, lavanulyl senecioate, 2-methyl    1-butanol, methyl eugenol, methyl jasmonate,    (E,Z)-2,13-octadecadien-1-ol, (E,Z)-2,13-octadecadien-1-ol acetate,    (E,Z)-3,13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone,    potassium silicate, sorbitol actanoate,    (E,Z,Z)-3,8,11-tetradecatrienyl acetate,    (Z,E)-9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-one,    Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal,    Z-11-tetradecen-1-ol, Acacia negra extract, extract of grapefruit    seeds and pulp, extract of Chenopodium ambrosiodae, Catnip oil, Neem    oil, Quillay extract, Tagetes oil,    -   and/or-   F.I) Respiration inhibitors-   F.I 1) Inhibitors of complex III at Q_(o) site (e.g. strobilurins):    azoxystrobin, coumethoxystrobin, coumoxystrobin, dimoxystrobin,    enestroburin, fenaminstrobin, fenoxystrobin/flufenoxystrobin,    fluoxastrobin, kresoxim-methyl, mandestrobine, metominostrobin,    orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin,    pyraoxystrobin, trifloxystrobin and    2-(2-(3-(2,6-dichlorophenyl)-1-methyl-allylideneaminooxymethyl)-phenyl)-2-methoxyimino-N-methyl-acetamide,    pyribencarb, triclopyricarb/chlorodincarb, famoxadone, fenamidone;-   F.I 2) inhibitors of complex III at Q_(i) site: cyazofamid,    amisulbrom,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate,    [(3S,6S,7R,8R)-8-benzyl-3-[[3-(1,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1,5-dioxonan-7-yl]    2-methylpropanoate;    (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2-pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1,5-dioxonan-7-yl    2-methylpropanoate;-   F.I 3) inhibitors of complex II (e. g. carboxamides): benodanil,    benzovindiflupyr, bixafen, boscalid, carboxin, fenfuram, fluopyram,    flutolanil, fluxapyroxad, furametpyr, isofetamid, isopyrazam,    mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane,    tecloftalam, thifluzamide,    N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,    N-(2-(1,3,3-trimethyl-butyl)-phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide,    3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1-methyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    3-(trifluoromethyl)-1,5-dimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    1,3,5-trimethyl-N-(1,1,3-trimethylindan-4-yl)pyrazole-4-carboxamide,    N-(7-fluoro-1,1,3-trimethyl-indan-4-yl)-1,3-dimethyl-pyrazole-4-carboxamide,    N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methyl-ethyl]-3-(difluoromethyl)-1-methylpyrazole-4-carboxamide,    N-[2-(2,4-difluorophenyl)phenyl]-3-(trifluoromethyl)pyrazine-2-carboxamide;-   F.I 4) other respiration inhibitors (e.g. complex I, uncouplers):    diflumetorim,    (5,8-difluoroquinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine;    nitrophenyl derivates: binapacryl, dinobuton, dinocap, fluazinam;    ferimzone; organometal compounds: fentin salts, such as    fentin-acetate, fentin chloride or fentin hydroxide; ametoctradin;    and silthiofam;-   F.II) Sterol biosynthesis inhibitors (SBI fungicides)-   F.II 1) C14 demethylase inhibitors (DMI fungicides): triazoles:    azaconazole, bitertanol, bromuconazole, cyproconazole,    difenoconazole, diniconazole, diniconazole-M, epoxiconazole,    fenbuconazole, fluquinconazole, flusilazole, flutriafol,    hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil,    oxpoconazole, paclobutrazole, penconazole, propiconazole,    prothioconazole, simeconazole, tebuconazole, tetraconazole,    triadimefon, triadimenol, triticonazole, uniconazole,-   1-[rel-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1H[1,2,4]triazole,    2-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,    1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-cyclopropyl-2-(1,2,4-triazol-1-yl)ethanol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol,    2-[2-chloro-4-(4-chlorophenoxy)phenyl]-3-methyl-1-(1,2,4-triazol-1-yl)butan-2-ol,    2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)pentan-2-ol,    2-[4-(4-fluorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol;    imidazoles: imazalil, pefurazoate, prochloraz, triflumizol;    pyrimidines, pyridines and piperazines: fenarimol, nuarimol,    pyrifenox, triforine,    [3-(4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol;-   F.II 2) Delta14-reductase inhibitors: aldimorph, dodemorph,    dodemorph-acetate, fenpropimorph, tridemorph, fenpropidin,    piperalin, spiroxamine;-   F.II 3) Inhibitors of 3-keto reductase: fenhexamid;-   F.III) Nucleic acid synthesis inhibitors-   F.II 1) phenylamides or acyl amino acid fungicides: benalaxyl,    benalaxyl-M, kiralaxyl, metalaxyl, metalaxyl-M (mefenoxam), ofurace,    oxadixyl;-   F.II 2) others: hymexazole, octhilinone, oxolinic acid, bupirimate,    5-fluorocytosine, 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine,    5-fluoro-2-(4-fluorophenylmethoxy)pyrimidin-4-amine;-   F.IV) Inhibitors of cell division and cytoskeleton-   F.IV 1) tubulin inhibitors, such as benzimidazoles, thiophanates:    benomyl, carbendazim, fuberidazole, thiabendazole,    thiophanate-methyl; triazolopyrimidines:    5-chloro-7-(4-methylpiperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine;-   F.IV 2) other cell division inhibitors: diethofencarb, ethaboxam,    pencycuron, fluopicolide, zoxamide, metrafenone, pyriofenone;-   F.V) Inhibitors of amino acid and protein synthesis-   F.V 1) methionine synthesis inhibitors (anilino-pyrimidines):    cyprodinil, mepanipyrim, pyrimethanil;-   F.V 2) protein synthesis inhibitors: blasticidin-S, kasugamycin,    kasugamycin hydrochloridehydrate, mildiomycin, streptomycin,    oxytetracyclin, polyoxine, validamycin A;-   F.VI) Signal transduction inhibitors-   F.VI 1) MAP/histidine kinase inhibitors: fluoroimid, iprodione,    procymidone, vinclozolin, fenpiclonil, fludioxonil;-   F.VI 2) G protein inhibitors: quinoxyfen;-   F.VII) Lipid and membrane synthesis inhibitors-   F.VII 1) Phospholipid biosynthesis inhibitors: edifenphos,    iprobenfos, pyrazophos, isoprothiolane;-   F.VII 2) lipid peroxidation: dicloran, quintozene, tecnazene,    tolclofos-methyl, biphenyl, chloroneb, etridiazole;-   F.VII 3) phospholipid biosynthesis and cell wall deposition:    dimethomorph, flumorph, mandipropamid, pyrimorph, benthiavalicarb,    iprovalicarb, valifenalate and    N-(1-(1-(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic    acid-(4-fluorophenyl) ester;-   F.VII 4) compounds affecting cell membrane permeability and fatty    acides: propamocarb, propamocarb-hydrochlorid;-   F.VII 5) fatty acid amide hydrolase inhibitors: oxathiapiprolin;-   F.VIII) Inhibitors with Multi Site Action-   F.VIII 1) inorganic active substances: Bordeaux mixture, copper    acetate, copper hydroxide, copper oxychloride, basic copper sulfate,    sulfur;-   F.VIII 2) thio- and dithiocarbamates: ferbam, mancozeb, maneb,    metam, metiram, propineb, thiram, zineb, ziram;-   F.VIII 3) organochlorine compounds (e.g. phthalimides, sulfamides,    chloronitriles): anilazine, chlorothalonil, captafol, captan,    folpet, dichlofluanid, dichlorophen, hexachlorobenzene,    pentachlorphenole and its salts, phthalide, tolylfluanid,    N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl-benzenesulfonamide;-   F.VIII 4) guanidines and others: guanidine, dodine, dodine free    base, guazatine, guazatineacetate, iminoctadine,    iminoctadine-triacetate, iminoctadine-tris(albesilate), dithianon,    2,6-dimethyl-1H,5H-[1,4]dithiino[2,3-c:5,6-c′]dipyrrole-1,3,5,7(2H,6H)-tetraone;-   F.IX) Cell wall synthesis inhibitors-   F.IX 1) inhibitors of glucan synthesis: validamycin, polyoxin B;-   F.IX 2) melanin synthesis inhibitors: pyroquilon, tricyclazole,    carpropamid, dicyclomet, fenoxanil;-   F.X) Plant defence inducers-   F.X 1) acibenzolar-S-methyl, probenazole, isotianil, tiadinil,    prohexadione-calcium;-   F.X 2) phosphonates: fosetyl, fosetyl-aluminum, phosphorous acid and    its salts,    4-cyclopropyl-N-(2,4-dimethoxyphenyl)thiadiazole-5-carboxamide;-   F.XI) Unknown mode of action-   bronopol, chinomethionat, cyflufenamid, cymoxanil, dazomet,    debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate,    diphenylamin, fenpyrazamine, flumetover, flusulfamide, flutianil,    methasulfocarb, nitrapyrin, nitrothal-isopropyl, oxathiapiprolin,    picarbutrazox, tolprocarb,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone,    oxin-copper, proquinazid, tebufloquin, tecloftalam, triazoxide,    2-butoxy-6-iodo-3-propylchromen-4-one,    N-(cyclopropylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl    acetamide,    N′-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl    formamidine,    N′-(5-difluoromethyl-2-methyl-4-(3-trimethylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl    formamidine, methoxy-acetic acid    6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester,    3-[5-(4-methylphenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine,    3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]-pyridine    (pyrisoxazole), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic    acid amide,    5-chloro-1-(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1H-benzoimidazole,    2-(4-chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide,    ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate, pentyl    N-[6-[[(Z)-[(1-methyltetrazol-5-yl)phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate,    2-[2-[(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol,    2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol,    3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline,    3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline,    3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline;-   F.XII) Biopesticides-   F.XII 1) Microbial pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: Ampelomyces    quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus    amyloliquefaciens, B. mojavensis, B. pumilus, B. simplex, B.    solisalsi, B. subtilis, B. subtilis var. amyloliquefaciens, Candida    oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages),    Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus    albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys    rosea f. catenulate (also named Gliocladium catenulatum),    Gliocladium roseum, Lysobacter antibioticus, L. enzymogenes,    Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis    ochracea, Muscodor albus, Paenibacillus polymyxa, Pantoea vagans,    Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis,    Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum,    Sphaerodes mycoparasitica, Streptomyces griseoviridis, S.    lydicus, S. violaceusniger, Talaromyces flavus, Trichoderma    atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum;    mixture of T. harzianum and T. viride; mixture of T. polysporum    and T. harzianum; T. stromaticum, T. virens (also named Gliocladium    virens), T. viride, Typhula phacorrhiza, Ulocladium oudemansii,    Verticillium dahlia, zucchini yellow mosaic virus (avirulent    strain);-   F.XII 2) Biochemical pesticides with fungicidal, bactericidal,    viricidal and/or plant defense activator activity: chitosan    (hydrolysate), harpin protein, laminarin, Menhaden fish oil,    natamycin, Plum pox virus coat protein, potassium or sodium    bicarbonate, Reynoutria sachlinensis extract, salicylic acid, tea    tree oil.

Preferred compounds I are stated above.

The methods and mixtures of the invention preferably include one or morepesticidal compounds II. More preferred the active compounds II and IIIemployed in the methods and mixtures of the inventions consist of one ormore compounds II, or of one or more compounds II and/or one or morecompounds III. If more than one compound of formula II and/or III isemployed it is preferably 2 or 3 compounds that are used.

Preferred active compounds II selected from groups M and L:

For each of the following the preferred combination partner I isbilobalide, ginkgolide A or a mixture of bilobalide and ginkgolide A.

With respect to their use in the methods and pesticidal mixtures of thepresent invention preference is given to compounds II selected from thegroups II-M.2B, II-M.3A, II-M.4A, II-M.5, II-M.6, II-M.10, II-M.13,II-M.21A, II-M.25, II-M.22, II-M23, II-M.28, II-M.UN and II-L.3.Particular preference is given to the groups II-M and L wherein the atleast one active compound II is selected from

-   II-M.2B within the class of fiproles from fipronil or ethiprole;-   II-M.3A within the class of pyrethroids from alpha-cypermethrin and    pyrethrum;-   II-M.4A within the class of neonicotinoids from acetamiprid,    chlothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid or    thiamethoxam;-   II-M.5 within the class of spinosyns from spinosad or spinetoram;-   II-M.6 within the class of mectins from abamectin or emamectin;-   II-M.10 within the mite growth inhibitors from etoxazole;-   II-M.13 within the uncouplers of oxidative phosphorylation from    chlorfenapyr;-   II-M.21A within the class of mitochondrial complex I electron    transport inhibitors from pyridaben, tebufenpyrad, tolfenpyrad or    flufenerim;-   II-M.25 within the class of mitochondrial complex II electron    transport inhibitors from cyenopyrafen and cyflumetofen;-   II-M.22 within the voltage-dependent sodium channel blockers from    indoxacarb or metaflumizone;-   II-M.23 within the inhibitors of the lipid synthesis from    spirodiclofen, spiromesifen or spirotetramat;-   II-M.28 within the class of diamides from flubendiamide,    chlorantraniliprole, cyantraniliprole, cyclaniliprole or    tetraniliprole;-   II-M.UN within the compounds of unknown or uncertain mode of action    from afidopyropene, afoxolaner, bifenazate, flupyradifurone,    fluralaner, piperonyl butoxide, pyridalyl, pyrifluquinazon,    sulfoxaflor or triflumezopyrim;-   II-M.BP-1 within the class of microbial pesticides from Bacillus    firmus, B. thuringiensis ssp. israelensis, B. t. ssp.    galleriae, B. t. ssp. kurstaki, Beauveria bassiana, Burkholderia sp.    or Paenibacillus poppiliae.

With regard to the use in a method and pesticidal mixture of the presentinvention, the compound II is preferably selected from group M-II.2.B asdefined above and is preferably fipronil or ethiprole, more preferablyfipronil.

With regard to the use in a method of the present invention, thecompound II is preferably selected from group M-II.3A defined above andis preferably alpha-cypermethrin, acrinathrin, bifenthrin, cyfluthrin,lambda-cyhalothrin, cypermethrin, beta-cypermethrin, zeta-cypermethrin,deltamethrin, esfenvalerate, etofenprox, fenpropathrin, flucythrinate,tau-fluvalinate, silafluofen or tralomethrin. Further preferred ispyrethrum.

More preferably the compound II is alpha-cypermethrin,lambda-cyhalothrin, bifenthrin, pyrethrum or deltamethrin, mostpreferably it is alpha-cypermethrin or pyrethrum.

With regard to the use in a method and pesticidal mixture of the presentinvention, the compound II is preferably selected from group M-II.4A asdefined above and is preferably acetamiprid, chlothianidin, dinotefuran,imidacloprid, nitenpyram, thiacloprid or thiamethoxam.

More preferably the compound II is acetamiprid.

More preferably the compound II is clothianidin.

More preferably the compound II is imidacloprid.

More preferably the compound II is thiamethoxam.

More preferably the compound II is dinotefuran.

With regard to the use in a method and pesticidal mixture of the presentinvention, the compound II is preferably selected from group M-II.5 asdefined above and is preferably spinosad.

With regard to the use in a method and pesticidal mixture of the presentinvention, the compound II is preferably selected from group M-II.6 asdefined above and is preferably abamectin, emamectin benzoate,lepimectin or milbemectin.

More preferably the compound II is abamectin.

More preferably the compound II is emamectin.

Most preferably the compound II is abamectin.

With regard to the use in a pesticidal mixture of the present invention,the compound II is preferably selected from group M-II.X (compounds ofunknown or uncertain mode of action) as defined above and is preferablyflupyradifurone or sulfoxaflor.

With regard to the use in a method and pesticidal mixture of the presentinvention, the compound II is preferably selected from group II-L.3(biopesticides).

More preferably the compound II is a microbial pesticide, mostpreferably Beauveria bassiana.

In a further embodiment compound (I) is not Beauveria bassiana.

Especially preferred are methods employing pesticidal mixturescontaining alpha-cypermethrin as compound II.

Especially preferred are methods employing pesticidal mixturescontaining pyrethrum as compound II.

Especially preferred are pesticidal mixtures containing fipronil orethiprole as compound II.

Especially preferred are pesticidal mixtures containing imidacloprid ascompound II.

Especially preferred are pesticidal mixtures containing acetamiprid ascompound II.

Especially preferred are pesticidal mixtures containing chlothianidineas compound II.

Especially preferred are pesticidal mixtures containing dinotefuran ascompound II.

Especially preferred are pesticidal mixtures containing nitenpyram ascompound II.

Especially preferred are pesticidal mixtures containing thiacloprid ascompound II.

Especially preferred are pesticidal mixtures containing spinosad ascompound II.

Especially preferred are pesticidal mixtures containing abamectin ascompound II.

Especially preferred are pesticidal mixtures containing sulfoxaflor ascompound II.

Especially preferred are pesticidal mixtures containing flupyradifuroneas compound II.

Especially preferred are pesticidal mixtures containing the compoundBeauveria bassiana as compound II.

Preferred fungicidal active compounds III selected from group F

With respect to their use in the pesticidal mixtures of the presentinvention, particular preference is given to certain fungicidal activecompounds III listed in the paragraphs below.

In a further preferred embodiment compound III is preferably selectedfrom group F.Ia).

More preferably the compound III is azoxystrobin, fluoxastrobin,picoxystrobin, pyraclostrobin or trifloxystrobin.

Most preferably the compound III is pyraclostrobin.

In a further preferred embodiment compound III is preferably selectedfrom group F.Ic).

More preferably the compound III is bixafen, boscalid, fluopyram,fluxapyroxad, isopyrazam, penflufen, penthiopyrad or sedaxane.

More preferably the compound III is fluxapyroxad.

More preferably the compound III is boscalid.

Most preferably the compound III is fluxapyroxad.

In a further preferred embodiment compound (III) is a thio ordithiocarbamate (F.VIII2), in particular mancozeb.

In a further preferred embodiment compound (III) is a respiratoryinhibitor (F.I4), preferably a nitrophenyl derivative, in particularamectotradin.

In a further preferred embodiment compound (III) is a tubulin inhibitor(F.IV2), in particular carbendazim.

In a further preferred embodiment compound (III) is a signaltransduction inhibitor (F.VI), preferably a MAP/histidine kinaseinhibitor, in particular iprodione.

In a further preferred embodiment compound (III) is a C14 demethylaseinhibitor (F.II), preferably a triazole, in particular epoxiconazole ordifenoconazole, or a imidazole, in particular prochloraz.

In a further preferred embodiment compound (III) is a organochlorinecompound (F.VIII3), in particular chlorothalonit.

In a further preferred embodiment compound (III) is a inhibitor of3-keto reductage (F.II3), in particular fenhexamid.

In a further preferred embodiment compound (III) is a methioninesynthesis inhibitor (F.V1), in particular pyrimethanil.

Preferred for application in the method of the invention or as mixtureof the invention are the mixtures shown in Table A.

TABLE A Preferred mixtures of the invention No Compound I Compound IICompound III 1. bilobalide alpha-cypermethrin 2. bilobalide fipronil 3.bilobalide ethiprole 4. bilobalide acetamiprid 5. bilobalidechlothianidin 6. bilobalide dinotefuran 7. bilobalide imidaclorid 8.bilobalide nitenpyram 9. bilobalide thiacloprid 10. bilobalidethiamethoxam 11. bilobalide spinosad 12. bilobalide abamectin 13.bilobalide flupyradifurone 14. bilobalide sulfoxaflor 15. bilobalideBeauveria bassiana 16. bilobalide pyraclostrobin 17. bilobalidefluxapyroxad 18. ginkgolide A alpha-cypermethrin 19. ginkgolide Afipronil 20. ginkgolide A ethiprole 21. ginkgolide A acetamiprid 22.ginkgolide A chlothianidin 23. ginkgolide A dinotefuran 24. ginkgolide Aimidaclorid 25. ginkgolide A nitenpyram 26. ginkgolide A thiacloprid 27.ginkgolide A thiamethoxam 28. ginkgolide A spinosad 29. ginkgolide Aabamectin 30. ginkgolide A flupyradifurone 31. ginkgolide A sulfoxaflor32. ginkgolide A Beauveria bassiana 33. ginkgolide A pyraclostrobin 34.ginkgolide A fluxapyroxad 35. bilobalide and ginkgolide Aalpha-cypermethrin 36. bilobalide and ginkgolide A fipronil 37.bilobalide and ginkgolide A ethiprole 38. bilobalide and ginkgolide Aacetamiprid 39. bilobalide and ginkgolide A chlothianidin 40. bilobalideand ginkgolide A dinotefuran 41. bilobalide and ginkgolide A imidaclorid42. bilobalide and ginkgolide A nitenpyram 43. bilobalide and ginkgolideA thiacloprid 44. bilobalide and ginkgolide A thiamethoxam 45.bilobalide and ginkgolide A spinosad 46. bilobalide and ginkgolide Aabamectin 47. bilobalide and ginkgolide A flupyradifurone 48. bilobalideand ginkgolide A sulfoxaflor 49. bilobalide and ginkgolide A Beauveriabassiana 50. bilobalide and ginkgolide A pyraclostrobin 51. bilobalideand ginkgolide A fluxapyroxad 52. ginkgolide B alpha-cypermethrin 53.ginkgolide B fipronil 54. ginkgolide B ethiprole 55. ginkgolide Bacetamiprid 56. ginkgolide B chlothianidin 57. ginkgolide B dinotefuran58. ginkgolide B imidaclorid 59. ginkgolide B nitenpyram 60. ginkgolideB thiacloprid 61. ginkgolide B thiamethoxam 62. ginkgolide B spinosad63. ginkgolide B abamectin 64. ginkgolide B flupyradifurone 65.ginkgolide B sulfoxaflor 66. ginkgolide B Beauveria bassiana 67.ginkgolide B pyraclostrobin 68. ginkgolide B fluxapyroxad 69. ginkgolideC alpha-cypermethrin 70. ginkgolide C fipronil 71. ginkgolide Cethiprole 72. ginkgolide C acetamiprid 73. ginkgolide C chlothianidin74. ginkgolide C dinotefuran 75. ginkgolide C imidaclorid 76. ginkgolideC nitenpyram 77. ginkgolide C thiacloprid 78. ginkgolide C thiamethoxam79. ginkgolide C spinosad 80. ginkgolide C abamectin 81. ginkgolide Cflupyradifurone 82. ginkgolide C sulfoxaflor 83. ginkgolide C Beauveriabassiana 84. ginkgolide C pyraclostrobin 85. ginkgolide C fluxapyroxad86. ginkgolide J alpha-cypermethrin 87. ginkgolide J fipronil 88.ginkgolide J ethiprole 89. ginkgolide J acetamiprid 90. ginkgolide Jchlothianidin 91. ginkgolide J dinotefuran 92. ginkgolide J imidaclorid93. ginkgolide J nitenpyram 94. ginkgolide J thiacloprid 95. ginkgolideJ thiamethoxam 96. ginkgolide J spinosad 97. ginkgolide J abamectin 98.ginkgolide J flupyradifurone 99. ginkgolide J sulfoxaflor 100.ginkgolide J Beauveria bassiana 101. ginkgolide J pyraclostrobin 102.ginkgolide J fluxapyroxad 103. ginkgolide M alpha-cypermethrin 104.ginkgolide M fipronil 105. ginkgolide M ethiprole 106. ginkgolide Macetamiprid 107. ginkgolide M chlothianidin 108. ginkgolide Mdinotefuran 109. ginkgolide M imidaclorid 110. ginkgolide M nitenpyram111. ginkgolide M thiacloprid 112. ginkgolide M thiamethoxam 113.ginkgolide M spinosad 114. ginkgolide M abamectin 115. ginkgolide Mflupyradifurone 116. ginkgolide M sulfoxaflor 117. ginkgolide MBeauveria bassiana 118. ginkgolide M pyraclostrobin 119. ginkgolide Mfluxapyroxad 120. bilobalide alpha-cypermethrin pyraclostrobin 121.bilobalide alpha-cypermethrin fluxapyroxad 122. bilobalide fipronilpyraclostrobin 123. bilobalide fipronil fluxapyroxad 124. bilobalideethiprole pyraclostrobin 125. bilobalide ethiprole fluxapyroxad 126.bilobalide acetamiprid pyraclostrobin 127. bilobalide acetamipridfluxapyroxad 128. bilobalide chlothianidin pyraclostrobin 129.bilobalide chlothianidin fluxapyroxad 130. bilobalide dinotefuranpyraclostrobin 131. bilobalide dinotefuran fluxapyroxad 132. bilobalideimidaclorid pyraclostrobin 133. bilobalide imidaclorid fluxapyroxad 134.bilobalide nitenpyram pyraclostrobin 135. bilobalide nitenpyramfluxapyroxad 136. bilobalide thiacloprid pyraclostrobin 137. bilobalidethiacloprid fluxapyroxad 138. bilobalide thiamethoxam pyraclostrobin139. bilobalide thiamethoxam fluxapyroxad 140. bilobalide spinosadpyraclostrobin 141. bilobalide spinosad fluxapyroxad 142. bilobalideabamectin pyraclostrobin 143. bilobalide abamectin fluxapyroxad 144.bilobalide flupyradifurone pyraclostrobin 145. bilobalideflupyradifurone fluxapyroxad 146. bilobalide sulfoxaflor pyraclostrobin147. bilobalide sulfoxaflor fluxapyroxad 148. bilobalide Beauveriabassiana pyraclostrobin 149. bilobalide Beauveria bassiana fluxapyroxad150. ginkgolide A alpha-cypermethrin pyraclostrobin 151. ginkgolide Aalpha-cypermethrin fluxapyroxad 152. ginkgolide A fipronilpyraclostrobin 153. ginkgolide A fipronil fluxapyroxad 154. ginkgolide Aethiprole pyraclostrobin 155. ginkgolide A ethiprole fluxapyroxad 156.ginkgolide A acetamiprid pyraclostrobin 157. ginkgolide A acetamipridfluxapyroxad 158. ginkgolide A chlothianidin pyraclostrobin 159.ginkgolide A chlothianidin fluxapyroxad 160. ginkgolide A dinotefuranpyraclostrobin 161. ginkgolide A dinotefuran fluxapyroxad 162.ginkgolide A imidaclorid pyraclostrobin 163. ginkgolide A imidacloridfluxapyroxad 164. ginkgolide A nitenpyram pyraclostrobin 165. ginkgolideA nitenpyram fluxapyroxad 166. ginkgolide A thiacloprid pyraclostrobin167. ginkgolide A thiacloprid fluxapyroxad 168. ginkgolide Athiamethoxam pyraclostrobin 169. ginkgolide A thiamethoxam fluxapyroxad170. ginkgolide A spinosad pyraclostrobin 171. ginkgolide A spinosadfluxapyroxad 172. ginkgolide A abamectin pyraclostrobin 173. ginkgolideA abamectin fluxapyroxad 174. ginkgolide A flupyradifuronepyraclostrobin 175. ginkgolide A flupyradifurone fluxapyroxad 176.ginkgolide A sulfoxaflor pyraclostrobin 177. ginkgolide A sulfoxaflorfluxapyroxad 178. ginkgolide A Beauveria bassiana pyraclostrobin 179.ginkgolide A Beauveria bassiana fluxapyroxad 180. bilobalide pyrethrum181. ginkgolide A pyrethrum 182. bilobalide + ginkgolide A pyrethrum183. bilobalide pyraclostrobin 184. ginkgolide A pyraclostrobin 185.bilobalide + ginkgolide A pyraclostrobin 186. bilobalide fluxapyroxad187. ginkgolide A fluxapyroxad 188. bilobalide + ginkgolide Afluxapyroxad 189. bilobalide mancozeb 190. ginkgolide A mancozeb 191.bilobalide + ginkgolide A mancozeb 192. bilobalide ametoctradin 193.ginkgolide A ametoctradin 194. bilobalide + ginkgolide A ametoctradin195. bilobalide carbendazim 196. ginkgolide A carbendazim 197.bilobalide + ginkgolide A carbendazim 198. bilobalide iprodion 199.ginkgolide A iprodion 200. bilobalide + ginkgolide A iprodion 201.bilobalide prochloraz 202. ginkgolide A prochloraz 203. bilobalide +ginkgolide A prochloraz 204. bilobalide chlorothalonil 205. ginkgolide Achlorothalonil 206. bilobalide + ginkgolide A chlorothalonil 207.bilobalide azoxystrobin 208. ginkgolide A azoxystrobin 209. bilobalide +ginkgolide A azoxystrobin 210. bilobalide trifloxystrobin 211.ginkgolide A trifloxystrobin 212. bilobalide + ginkgolide Atrifloxystrobin 213. bilobalide fenhexamid 214. ginkgolide A fenhexamid215. bilobalide + ginkgolide A fenhexamid 216. bilobalide pyrimethanil217. ginkgolide A pyrimethanil 218. bilobalide + ginkgolide Apyrimethanil 219. bilobalide epoxiconazol 220. ginkgolide A epoxiconazol221. bilobalide + ginkgolide A epoxiconazol 222. bilobalidepicoxystrobin 223. ginkgolide A picoxystrobin 224. bilobalide +ginkgolide A picoxystrobin 225. bilobalide difenoconazol 226. ginkgolideA difenoconazol 227. bilobalide + ginkgolide A difenoconazol

Pests

The compounds applied in the methods of the invention are used,preferably on soybean and/or maize (Zea mays), to control pests from thefamily of Pentatomidae, particularly stinkbugs, e.g. Nezara spp. (e.g.Nezara viridula, Nezara antennata, Nezara hilaris), Piezodorus spp.(e.g. Piezodorus guildinii), Acrosternum spp. (e.g. Acrosternum hilare),Euchistus spp. (e.g. Euchistus heros, Euschistus servus), Halyomorphahalys, Megacopta cribaria, Plautia crossota, Riptortus clavatus,Rhopalus msculatus, Antestiopsis orbitalus, Dectes texanus, Dichelopsspp. (e.g. Dichelops furcatus, Dichelops melacanthus), Eurygaster spp.(e.g. Eurygaster intergriceps, Eurygaster maurd), Oebalus spp. (e.g.Oebalus mexicana, Oebalus poecilus, Oebalus pugnase, Scotinophara spp.(e.g. Scotinophara lurida, Scotinophara coarctatd). Preferred targetsinclude Acrosternum hilare, Antestiopsis orbitalus, Dichelops furcatus,Dichelops melacanthus, Euchistus heros, Euschistus servus, Megacoptacribaria, Nezara viridula, Nezara hilare, Piezodorus guildinii,Halyomorpha halys. In one embodiment the stinkbug target is Nezaraviridula, Piezodorus spp., Acrosternum spp, Euchistus heros. Euschistusand in particular Euchistus heros are preferred targets.

Further pests in particular of soybeans and/or maize that can becontrolled with the mixtures of the invention include Elasmopalpuslignosellus, Diloboderus abderus, Diabrotica speciosa, Sternechussubsignatus, Formicidae, Agrotis ipsilon, Julus ssp., Anticarsiagemmatalis, Megacopta spp., Megascelis ssp., Procornitermes ssp.,Gryllotalpidae, Nezara viridula, Neomegalotomus spp., Cerotomatrifurcata, Popillia japonica, Edessa spp., Liogenys fuscus, stem borer,Dectes spp, stalk borer, Scaptocoris castanea, phyllophaga spp.,Pseudoplusia includens, Spodoptera spp., Bemisia tabaci, Agriotes spp.,Thripidae, preferably Diloboderus abderus, Diabrotica speciosa,Piezodorus spp., Cerotoma trifurcata, Popillia japonica, Phyllophagaspp. Agriotes spp.

Depending on the spectrum of activity of the compounds II, mixtures ofthe invention can be used for the control of:

-   insects from the order of the lepidopterans (Lepidoptera), such as    Heliothis spp., e.g. Heliothis virescens,-   beetles (Coleoptera), such as Anthonomus spp., e.g. Anthonomus    grandis, flies, mosquitoes (Diptera), such as Ceratitis spp., e.g.    Ceratitis capitata, Aedes spp., e.g.-   Aedes aegypti,-   termites (Isoptera),-   cockroaches (Blattaria-Blattodea),-   bugs, aphids, leafhoppers, whiteflies, scale insects, cicadas    (Hemiptera),-   ants, bees, wasps, sawflies (Hymenoptera),-   crickets, grasshoppers, locusts (Orthoptera),-   arachnids (Arachnida),-   fleas (Siphonaptera),-   silverfish, firebrat (Thysanura),-   centipedes (Chilopoda),-   millipedes (Diplopoda),-   earwigs (Dermaptera),-   lice (Phthiraptera),-   springtails (Collembola),-   and-   plant parasitic nematodes.

Depending on the spectrum of activity of the compounds III, mixtures ofthe invention can be used for the control of phytopathogenic fungi andfungus-like eukaryotic microorganisms from Ascomycetes, Basidiomycetes,Deuteromycetes and Peremosporomycetes (syn. Domycetes).

Phytophtora such as Examples of pathogens are Phytophtora infestans,Botrytis, such as Botrytis cinerea, Pyricularia such as Pyriculariaoryzae, Septoria such as Septoria tritici, Alternaria such as Alternariasolani and Leptosphaeria, such as Leptosphaeria nodorum.

Some of them are systemically effective and can be employed in cropprotection as foliar fungicides, as fungicides for seed dressing and assoil fungicides. They can also be used for treating seed.

They are particularly important in the control of a multitude of fungion various cultivated plants, such as maize, wheat, rye, barley, oats,rice, corn, lawns, bananas, cotton, soybean, lima bean, coffee, sugarcane, grapevines, fruits and ornamental plants and vegetables such ascucumbers, beans, tomatoes, potatoes and curcurbits, and on the seeds ofthese plants.

Formulations

The mixtures according to the invention and applied in the methods ofthe invention can be converted into the customary formulations, forexample solutions, emulsions, suspensions, dusts, powders, pastes andgranules. The use form depends on the particular intended purpose; ineach case, it should ensure a fine and even distribution of thecompounds according to the invention.

Therefore the invention also relates to agrochemical compositionscomprising an auxiliary and a mixture of at least one compound I offormula I and of at least one compound II and/or one compound IIIaccording to the present invention.

An agrochemical composition comprises a pesticidally effective amount ofa compound I. The term “effective amount” denotes an amount of thecomposition or of the compounds I, which is sufficient for controllingharmful pests on cultivated plants or in the protection of materials andwhich does not result in a substantial damage to the treated plants.Such an amount can vary in a broad range and is dependent on variousfactors, such as the fungal species and/or the pest species to becontrolled, the treated cultivated plant or material, the climaticconditions and the specific compound I used.

The active compounds I and II and/or III, their N-oxides and salts canbe converted into customary types of agrochemical compositions, e. g.solutions, emulsions, suspensions, dusts, powders, pastes, granules,pressings, capsules, and mixtures thereof. Examples for compositiontypes are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g.EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes,pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS),pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG),insecticidal articles (e.g. LN), as well as gel formulations for thetreatment of plant propagation materials such as seeds (e.g. GF). Theseand further compositions types are defined in the “Catalogue ofpesticide formulation types and international coding system”, TechnicalMonograph No. 2, 6th Ed. May 2008, CropLife International.

The compositions are prepared in a known manner, such as described byMollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001;or Knowles, New developments in crop protection product formulation,Agrow Reports DS243, T&F Informa, London, 2005.

Suitable auxiliaries are solvents, liquid carriers, solid carriers orfillers, surfactants, dispersants, emulsifiers, wetters, adjuvants,solubilizers, penetration enhancers, protective colloids, adhesionagents, thickeners, humectants, repellents, attractants, feedingstimulants, compatibilizers, bactericides, anti-freezing agents,anti-foaming agents, colorants, tackifiers and binders.

Suitable solvents and liquid carriers are water and organic solvents,such as mineral oil fractions of medium to high boiling point, e.g.kerosene, diesel oil; oils of vegetable or animal origin; aliphatic,cyclic and aromatic hydrocarbons, e. g. toluene, paraffin,tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol,propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones,e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acidesters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides,e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixturesthereof.

Suitable solid carriers or fillers are mineral earths, e.g. silicates,silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite,diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate,magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers,e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas;products of vegetable origin, e.g. cereal meal, tree bark meal, woodmeal, nutshell meal, and mixtures thereof.

Suitable surfactants are surface-active compounds, such as anionic,cationic, nonionic and amphoteric surfactants, block polymers,polyelectrolytes, and mixtures thereof. Such surfactants can be used asemulsifier, dispersant, solubilizer, wetter, penetration enhancer,protective colloid, or adjuvant. Examples of surfactants are listed inMcCutcheon's, Vol. 1: Emulsifiers & Detergents, McCutcheon'sDirectories, Glen Rock, USA, 2008 (International Ed. or North AmericanEd.).

Suitable anionic surfactants are alkali, alkaline earth or ammoniumsalts of sulfonates, sulfates, phosphates, carboxylates, and mixturesthereof. Examples of sulfonates are alkylarylsulfonates,diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates,sulfonates of fatty acids and oils, sulfonates of ethoxylatedalkylphenols, sulfonates of alkoxylated arylphenols, sulfonates ofcondensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes,sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates orsulfosuccinamates. Examples of sulfates are sulfates of fatty acids andoils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols,or of fatty acid esters. Examples of phosphates are phosphate esters.Examples of carboxylates are alkyl carboxylates, and carboxylatedalcohol or alkylphenol ethoxylates.

Suitable nonionic surfactants are alkoxylates, N-substituted fatty acidamides, amine oxides, esters, sugar-based surfactants, polymericsurfactants, and mixtures thereof. Examples of alkoxylates are compoundssuch as alcohols, alkylphenols, amines, amides, arylphenols, fatty acidsor fatty acid esters which have been alkoxylated with 1 to 50equivalents. Ethylene oxide and/or propylene oxide may be employed forthe alkoxylation, preferably ethylene oxide. Examples of N-substitutedfatty acid amides are fatty acid glucamides or fatty acid alkanolamides.Examples of esters are fatty acid esters, glycerol esters ormonoglycerides. Examples of sugar-based surfactants are sorbitans,ethoxylated sorbitans, sucrose and glucose esters oralkylpolyglucosides. Examples of polymeric surfactants are homo- orcopolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.

Suitable cationic surfactants are quaternary surfactants, for examplequaternary ammonium compounds with one or two hydrophobic groups, orsalts of long-chain primary amines. Suitable amphoteric surfactants arealkylbetains and imidazolines. Suitable block polymers are blockpolymers of the A-B or A-B-A type comprising blocks of polyethyleneoxide and polypropylene oxide, or of the A-B—C type comprising alkanol,polyethylene oxide and polypropylene oxide. Suitable polyelectrolytesare polyacids or polybases. Examples of polyacids are alkali salts ofpolyacrylic acid or polyacid comb polymers. Examples of polybases arepolyvinylamines or polyethyleneamines.

Suitable adjuvants are compounds, which have a neglectable or even nopesticidal activity themselves, and which improve the biologicalperformance of the compound I on the target. Examples are surfactants,mineral or vegetable oils, and other auxilaries. Further examples arelisted by Knowles, Adjuvants and additives, Agrow Reports DS256, T&FInforma UK, 2006, chapter 5.

Suitable thickeners are polysaccharides (e.g. xanthan gum,carboxymethylcellulose), anorganic clays (organically modified orunmodified), polycarboxylates, and silicates.

Suitable bactericides are bronopol and isothiazolinone derivatives suchas alkylisothiazolinones and benzisothiazolinones.

Suitable anti-freezing agents are ethylene glycol, propylene glycol,urea and glycerin.

Suitable anti-foaming agents are silicones, long chain alcohols, andsalts of fatty acids.

Suitable colorants (e.g. in red, blue, or green) are pigments of lowwater solubility and water-soluble dyes. Examples are inorganiccolorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) andorganic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).

Suitable tackifiers or binders are polyvinylpyrrolidons,polyvinylacetates, polyvinyl alcohols, polyacrylates, biological orsynthetic waxes, and cellulose ethers.

The agrochemical compositions generally comprise between 0.01 and 95%,preferably between 0.1 and 90%, and in particular between 0.5 and 75%,by weight of active substance. The active substances are employed in apurity of from 90% to 100%, preferably from 95% to 100% (ac-cording toNMR spectrum).

Solutions for seed treatment (LS), Suspoemulsions (SE), flowableconcentrates (FS), powders for dry treatment (DS), water-dispersiblepowders for slurry treatment (WS), water-soluble powders (SS), emulsions(ES), emulsifiable concentrates (EC) and gels (GF) are usually employedfor the purposes of treatment of plant propagation materials,particularly seeds. The compositions in question give, aftertwo-to-tenfold dilution, active substance concentrations of from 0.01 to60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-usepreparations. Application can be carried out before or during sowing.Methods for applying compound I and compositions thereof, respectively,on to plant propagation material, especially seeds include dressing,coating, pelleting, dusting, soaking and in-furrow application methodsof the propagation material. Preferably, compound I or the compositionsthereof, respectively, are applied on to the plant propagation materialby a method such that germination is not induced, e. g. by seeddressing, pelleting, coating and dusting.

When employed in plant protection, the amounts of active substancesapplied are, depending on the kind of effect desired, from 0.001 to 2 kgper ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05to 0.9 kg per ha, and in particular from 0.1 to 0.75 kg per ha.

In treatment of plant propagation materials such as seeds, e. g. bydusting, coating or drenching seed, amounts of active substance of from0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to100 g and most preferably from 5 to 100 g, per 100 kilogram of plantpropagation material (preferably seeds) are generally required. In somecases the amount for seed treatment may be up to 100 kilogram per 100kilogram of seeds, or may even excess the seed weight.

When used in the protection of materials or stored products, the amountof active substance applied depends on the kind of application area andon the desired effect. Amounts customarily applied in the protection ofmaterials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of activesubstance per cubic meter of treated material.

Various types of oils, wetters, adjuvants, fertilizer, ormicronutrients, and further pesticides (e.g. herbicides, insecticides,fungicides, growth regulators, safeners) may be added to the activesubstances or the compositions comprising them as premix or, ifappropriate not until immediately prior to use (tank mix). These agentscan be admixed with the compositions according to the invention in aweight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.

The user applies the composition according to the invention usually froma predosage device, a knapsack sprayer, a spray tank, a spray plane, oran irrigation system. Usually, the agrochemical composition is made upwith water, buffer, and/or further auxiliaries to the desiredapplication concentration and the ready-to-use spray liquor or theagrochemical composition according to the invention is thus obtained.Usually, 20 to 2000 liters, preferably 50 to 400 liters, of theready-to-use spray liquor are applied per hectare of agricultural usefularea.

According to one embodiment, individual components of the compositionaccording to the invention such as parts of a kit or parts of a binaryor ternary mixture may be mixed by the user himself in a spray tank andfurther auxiliaries may be added, if appropriate.

In a further embodiment, either individual components of the compositionaccording to the invention or partially premixed components, e. g.components comprising active compound I and active compounds II (andoptionally active compounds III), may be mixed by the user in a spraytank and further auxiliaries and additives may be added, if appropriate.

In a further embodiment, either individual components of the compositionaccording to the invention or partially premixed components, e. g.components comprising active compound I and active compounds II and/orIII, can be applied jointly (e.g. after tank mix) or consecutively.

Applications

The compound I and the one or more compound(s) II and/or III can beapplied simultaneously, that is jointly or separately, or in succession,that is immediately one after another and thereby creating the mixture“in-situ” on the desired location, as e.g. the plant, the sequence, inthe case of separate application, generally not having any effect on theresult of the control measures.

The mixtures of the invention are employed as such or in form ofcompositions by treating the insects or the plants, plant propagationmaterials, such as seeds, soil, surfaces, materials or rooms to beprotected from insecticidal attack with an insecticidally effectiveamount of the active compounds. The application can be carried out bothbefore and after the infection of the plants, plant propagationmaterials, such as seeds, soil, surfaces, materials or rooms by theinsects.

In the mixtures and compositions according to the invention, the weightratio of the compound I and compound II or III generally depends fromthe properties of the compounds II or III used, usually it is in therange of from 10 000:1 to 1:10, regularly in the range of from 7500:1 to1:5, preferably in the range of from 5000:1 to 1:5, more preferably inthe range of from 1000:1 to 1:2, even more preferably in the range offrom 500:1 to 5:1 and in particular in the range of from 300:1 to 5:1.

According to further embodiments of the mixtures according to theinvention, the weight ratio of compound I to compound II usually is inthe range of from 10 000:1 to 1:10, regularly in the range of from5000:1 to 1:5, preferably in the range of from 3000:1 to 1:2, morepreferably in the range of from 1000:1 to 1:1, even more preferably inthe range of from 500:1 to 1:1 and in particular in the range of from250:1 to 5:1.

According to further embodiments of the mixtures according to theinvention, the weight ratio of compound I to compound III usually is inthe range of from 5000:1 to 1:5, regularly in the range of from 2000:1to 1:1, preferably in the range of from 1500:1 to 1:1, more preferablyin the range of from 1000:1 to 2:1, even more preferably in the range offrom 500:1 to 5:1 and in particular in the range of from 300:1 to 1:10.

In the ternary mixtures, i.e. compositions according to the inventioncomprising compound I (component 1) and a compound II (component 2) anda compound III (component 3), the weight ratio of component 1) andcomponent 2) depends from the properties of the active substances used.In one embodiment the amounts of compounds I, II and III are derivedfrom the above values for the weight ratios of compounds I and compoundsII and III respectively.

Typical values for certain classes of compounds (with compound (I) beingpreferably bilobalide or ginkgolide A) are: Neonicotinoids, such asdinotefuran, midacloprid and thiamethoxam (weight ratio compound (I) tocompound (III) 10 000:1 to 1:1, preferably 7500:1 to 50 to 1, morepreferred 5000:1 to 100 to 1, in particular 4500 to 1 to 150 to 1.

For synthetic pyrethroids, such as α-cypermethrin the ratios forneonicotinoids are applicable.

The same applies for chloride channel activators, preferably avermectinssuch as abamectin.

For pyrethrum and nicotinic acetylcholine receptor allostericactivators, preferably spinosyns, such as spinosad, a typical ratio is(I:II): 100:1 to 1 to 100, preferably 10:1 to 1:50, more preferably 5:1to 1:10, in particular 1:2 to 1:5, specifically 1:1 to 1:3.

Strobilurines, such as pyraclostrobin, azoxystrobin, trifluxystrobin andpicoxystrobin (I:III) 5000:1 to 1:1, preferably 2000:1 to 10:1, morepreferably 1000:1 to 1:50.

For other fungicides such as fluxapyroxad, mancozeb, ametoctradin,carbendazim, iprodion, prochloraz, chlorothalonil, fenhexamid,pyrimethanil, epoxiconazol and difenoconazol, as well as for the classesof fungicides they represent typical weight ratios (I:III) are 250:1 to1:5, preferably 200:1 to 1:1, more preferred 150:1 to 1:2, in particular100:1 to 1:2, especially 80:1 to 1:5.

In a further embodiment, the weight ratio of the compound I and compoundII or III is in the range of from 1:100 to 100:1, regularly in the rangeof from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, morepreferably in the range of from 1:10 to 10:1, even more preferably inthe range of from 1:4 to 4:1 and in particular in the range of from 1:2to 2:1.

According to further embodiments of the mixtures according to theinvention, the weight ratio of compound I to compound II or III usuallyis in the range of from 100:1 to 1:1, regularly in the range of from50:1 to 1:1, preferably in the range of from 20:1 to 1:1, morepreferably in the range of from 10:1 to 1:1, even more preferably in therange of from 4:1 to 1:1 and in particular in the range of from 2:1 to1:1.

According to further embodiments of the mixtures according to theinvention, the weight ratio of compound I to compound II or III usuallyis in the range of from 1:1 to 1:100, regularly in the range of from 1:1to 1:50, preferably in the range of from 1:1 to 1:20, more preferably inthe range of from 1:1 to 1:10, even more preferably in the range of from1:1 to 1:4 and in particular in the range of from 1:1 to 1:2.

In one embodiment compound 1 is used in excess as compared to compoundII or III, i.e. the weight ratio of compound I to compound II or IIIusually is in the range of from 100:1 to 1:1, regularly in the range offrom 50:1 to 1:1, preferably in the range of from 20:1 to 1:1, morepreferably in the range of from 10:1 to 1:1, even more preferably in therange of from 4:1 to 1:1, e.g. of from 3:1 to 1:1, and in particular inthe range of from 2:1 to 1:1.

In a further embodiment of ternary mixtures, i.e. compositions accordingto the invention comprising compound I (component 1) and a compound II(component 2) and a compound III (component 3), the weight ratio ofcomponent 1) and component 2) usually it is in the range of from 1:100to 100:1, regularly in the range of from 1:50 to 50:1, preferably in therange of from 1:20 to 20:1, more preferably in the range of from 1:10 to10:1 and in particular in the range of from 1:4 to 4:1, and the weightratio of component 1) and component 3) usually it is in the range offrom 1:100 to 100:1, regularly in the range of from 1:50 to 50:1,preferably in the range of from 1:20 to 20:1, more preferably in therange of from 1:10 to 10:1 and in particular in the range of from 1:4 to4:1.

Any further active components are, if desired, added in a ratio of from20:1 to 1:20 to compound I.

In further embodiments of the invention the compound I and the one ormore compound(s) II and/or III are applied in a weight ratio of from500:1 to 1:100, preferably from 20:1 to 1:50, in particular from 5:1 to1:20.

For microbial pesticides in one embodiment the ratio of microbialpesticide to compound (I) is from 1×10E4 CFU/ml to 1×10E8 CFU/ml perppm, preferably from 1×10E4 CFU/ml to 1×10E7 CFU/ml per ppm, morepreferably from 5×10E4 CFU/ml to 5×10E6 CFU/ml per ppm, in particular7.5×10E4 CFU/ml to 7.5×10E5 CFU/ml per ppm.

This may apply e.g. if compound (II) is Beauveria basiana.

In a further embodiment, the ratio of microbial pesticide to compound(I) is from 1×10E4 CFU/ml to 1×10E8 CFU/ml per ppm, preferably from1×10E % CFU/ml to 1×10E7 CFU/ml per ppm, more preferably from 5×10E %CFU/ml to 5×10E6 CFU/ml per ppm (CFU-colony forming unit) Depending onthe desired effect, the application rates of the mixtures according tothe invention are from 5 g/ha to 2000 g/ha, preferably from 50 to 1500g/ha, in particular from 50 to 750 g/ha.

The mixtures according to the invention are effective through bothcontact and ingestion.

According to a preferred embodiment of the invention, the mixturesaccording to the present invention are employed via soil application.Soil application is especially favorable for use against ants, termites,crickets, or cockroaches.

According to another preferred embodiment of the invention, for useagainst non-crop pests such as ants, termites, wasps, flies, mosquitoes,crickets, locusts, or cockroaches the mixtures according to the presentinvention are prepared into a bait preparation.

The bait can be a liquid, a solid or a semisolid preparation (e.g. agel).

Another aspect of the present invention is when preparing the mixtures,it is preferred to employ the pure active compounds I and II, to whichfurther active compounds, e.g. against harmful fungi or havingherbicidal activity, or growth-regulating agents or fertilizers can beadded.

Compositions of this invention may further contain other activeingredients than those listed above. For example fungicides, herbicides,fertilizers such as ammonium nitrate, urea, potash, and superphosphate,phytotoxicants and plant growth regulators and safeners. Theseadditional ingredients may be used sequentially or in combination withthe above-described compositions, if appropriate also added onlyimmediately prior to use (tank mix). For example, the plant(s) may besprayed with a composition of this invention either before or afterbeing treated with other active ingredients.

The mixtures according to the invention can be applied to any and alldevelopmental stages, such as egg, larva, pupa, and adult. The pests maybe controlled by contacting the target pest, its food supply, habitat,breeding ground or its locus with a pesticidally effective amount of theinventive mixtures or of compositions comprising the mixtures.

“Locus” means a plant, seed, soil, area, material or environment inwhich a pest is growing or may grow.

In general, “pesticidally effective amount” means the amount of theinventive mixtures or of compositions comprising the mixtures needed toachieve an observable effect on growth, including the effects ofnecrosis, death, retardation, prevention, and removal, destruction, orotherwise diminishing the occurrence and activity of the targetorganism. The pesticidally effective amount can vary for the variousmixtures and/or compositions used in the invention. A pesticidallyeffective amount of the mixtures and/or compositions will also varyaccording to the prevailing conditions such as desired pesticidal effectand duration, weather, target species, locus, mode of application, andthe like.

The inventive mixtures or compositions of these mixtures can also beemployed for protecting plants from attack or infestation by insects,acarids or nematodes comprising contacting a plant, or soil or water inwhich the plant is growing.

The inventive mixtures are effective through both contact (via soil,glass, wall, bed net, carpet, plant parts or animal parts), andingestion (bait, or plant part) and through trophallaxis and transfer.

Preferred application methods are into water bodies, via soil, cracksand crevices, pastures, manure piles, sewers, into water, on floor,wall, or by perimeter spray application and bait.

According to another preferred embodiment of the invention, for useagainst non-crop pests such as ants, termites, wasps, flies, mosquitoes,crickets, locusts, or cockroaches the inventive mixtures are preparedinto a bait preparation.

The bait can be a liquid, a solid or a semisolid preparation (e.g. agel). The bait employed in the composition is a product which issufficiently attractive to incite insects such as ants, termites, wasps,flies, mosquitoes, crickets etc. or cockroaches to eat it. Thisattractant may be chosen from feeding stimulants or para and/or sexpheromones readily known in the art.

Methods to control infectious diseases transmitted by insects (e.g.malaria, dengue and yellow fever, lymphatic filariasis, andleishmaniasis) with the inventive mixtures and their respectivecompositions also comprise treating surfaces of huts and houses, airspraying and impregnation of curtains, tents, clothing items, bed nets,tsetse-fly trap or the like. Insecticidal compositions for applicationto fibers, fabric, knit goods, non-wovens, netting material or foils andtarpaulins preferably comprise a composition including the inventivemixtures, optionally a repellent and at least one binder.

The inventive mixtures and the compositions comprising them can be usedfor protecting wooden materials such as trees, board fences, sleepers,etc. and buildings such as houses, outhouses, factories, but alsoconstruction materials, furniture, leathers, fibers, vinyl articles,electric wires and cables etc. from ants and/or termites, and forcontrolling ants and termites from doing harm to crops or human being(e.g. when the pests invade into houses and public facilities).

In the case of soil treatment or of application to the pests dwellingplace or nest, the quantity of active ingredient(s) ranges from 0.0001to 500 g per 100 m², preferably from 0.001 to 20 g per 100 m².

Customary application rates in the protection of materials are, forexample, from 0.01 g to 1000 g of active compound(s) per m² treatedmaterial, desirably from 0.1 g to 50 g per m².

Insecticidal compositions for use in the impregnation of materialstypically contain from 0.001 to 95 weight %, preferably from 0.1 to 45weight %, and more preferably from 1 to 25 weight % of at least onerepellent and/or insecticide.

For use in bait compositions, the typical content of activeingredient(s) is from 0.0001 weight % to 15 weight %, desirably from0.001 weight % to 5 weight % of active compound. The composition usedmay also comprise other additives such as a solvent of the activematerial, a flavoring agent, a preserving agent, a dye or a bitteragent. Its attractiveness may also be enhanced by a special color, shapeor texture.

For use in spray compositions, the content of the mixture of the activeingredients is from 0.001 to 80 weight %, preferably from 0.01 to 50weight % and most preferably from 0.01 to 15 weight %.

For use in treating crop plants, the rate of application of the mixtureof the active ingredients of this invention may be in the range of 0.1 gto 4000 g per hectare, desirably from 25 g to 600 g per hectare, moredesirably from 50 g to 500 g per hectare.

In the context of the present invention, the term plant refers to anentire plant, a part of the plant or the plant propagation material.

The mixtures of the present invention and the compositions comprisingthem are particularly important in the control of a multitude of insectson various cultivated plants.

Plants which can be treated with the inventive mixtures include allgenetically modified plants or transgenic plants, e.g. crops whichtolerate the action of herbicides or fungicides or insecticides owing tobreeding, including genetic engineering methods, or plants which havemodified characteristics in comparison with existing plants, which canbe generated for example by traditional breeding methods and/or thegeneration of mutants, or by recombinant procedures.

The term “plant propagation material” is to be understood to denote allthe generative parts of the plant such as seeds and vegetative plantmaterial such as cuttings and tubers (e. g. potatoes), which can be usedfor the multiplication of the plant. This includes seeds, roots, fruits,tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants.Seedlings and young plants, which are to be transplanted aftergermination or after emergence from soil, may also be mentioned. Theseyoung plants may also be protected before transplantation by a total orpartial treatment by immersion or pouring.

The term “cultivated plants” is to be understood as including plantswhich have been modified by breeding, mutagenesis or geneticengineering. Genetically modified plants are plants, which geneticmaterial has been so modified by the use of recombinant DNA techniquesthat under natural circumstances cannot be obtained by cross breeding,mutations or natural recombination. Typically, one or more genes havebeen integrated into the genetic material of a genetically modifiedplant in order to improve certain properties of the plant.

The term “cultivated plants” is to be understood also including plantsthat have been rendered tolerant to applications of specific classes ofherbicides, such as hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors;acetolactate synthase (ALS) inhibitors, such as sulfonyl ureas (see e.g. U.S. Pat. No. 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO98/02526, WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO03/13225, WO 03/14356, WO 04/16073) or imidazolinones (see e. g. U.S.Pat. No. 6,222,100, WO 01/82685, WO 00/26390, WO 97/41218, WO 98/02526,WO 98/02527, WO 04/106529, WO 05/20673, WO 03/14357, WO 03/13225, WO03/14356, WO 04/16073); enolpyruvylshikimate-3-phosphate synthase(EPSPS) inhibitors, such as glyphosate (see e. g. WO 92/00377);glutamine synthetase (GS) inhibitors, such as glufosinate (see e. g.EP-A-0242236, EP-A-242246) or oxynil herbicides (see e. g. U.S. Pat. No.5,559,024) as a result of conventional methods of breeding or geneticengineering. Several cultivated plants have been rendered tolerant toherbicides by conventional methods of breeding (mutagenesis), forexample Clearfield® summer rape (Canola) being tolerant toimidazolinones, e. g. imazamox. Genetic engineering methods have beenused to render cultivated plants, such as soybean, cotton, corn, beetsand rape, tolerant to herbicides, such as glyphosate and glufosinate,some of which are commercially available under the trade namesRoundupReady® (glyphosate) and LibertyLink® (glufosinate).

The term “cultivated plants” is to be understood also including plantsthat are by the use of recombinant DNA techniques capable to synthesizeone or more insecticidal proteins, especially those known from thebacterial genus Bacillus, particularly from Bacillus thuringiensis, suchas ä-endotoxins, e. g. CryIA(b), CryIA(c), CryIF, CryIF(a2), CryIIA(b),CryIIIA, CryIIIB(b1) or Cry9c; vegetative insecticidal proteins (VIP),e. g. VIP1, VIP2, VIP3 or VIP3A; insecticidal proteins of bacteriacolonizing nematodes, for example Photorhabdus spp. or Xenorhabdus spp.;toxins produced by animals, such as scorpion toxins, arachnid toxins,wasp toxins, or other insect-specific neurotoxins; toxins produced byfungi, such Streptomycetes toxins, plant lectins, such as pea or barleylectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors,serine protease inhibitors, patatin, cystatin or papain inhibitors;ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin,luffin, saporin or bryodin; steroid metabolism enzymes, such as3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyl-transferase,cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ionchannel blockers, such as blockers of sodium or calcium channels;juvenile hormone esterase; diuretic hormone receptors (helicokininreceptors); stilben synthase, bibenzyl synthase, chitinases orglucanases. In the context of the present invention these insecticidalproteins or toxins are to be understood expressly also as pre-toxins,hybrid proteins, truncated or otherwise modified proteins. Hybridproteins are characterized by a new combination of protein domains,(see, for example WO 02/015701). Further examples of such toxins orgenetically-modified plants capable of synthesizing such toxins aredisclosed, for example, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A427 529, EP-A 451 878, WO 03/018810 und WO 03/052073. The methods forproducing such genetically modified plants are generally known to theperson skilled in the art and are described, for example, in thepublications mentioned above. These insecticidal proteins contained inthe genetically modified plants impart to the plants producing theseproteins tolerance to harmful pests from all taxonomic groups ofinsects, especially to beetles (Coeloptera), two-winged insects(Diptera), and butterflies (Lepidoptera).

The term “cultivated plants” is to be understood also including plantsthat are by the use of recombinant DNA techniques capable to synthesizeone or more proteins to increase the resistance or tolerance of thoseplants to bacterial, viral or fungal pathogens. Examples of suchproteins are the so-called “pathogenesis-related proteins” (PR proteins,see, for example EP-A 0 392 225), plant disease resistance genes (forexample potato cultivars, which express resistance genes acting againstPhytophthora infestans derived from the mexican wild potato Solanumbulbocastanum) or T4-lysozym (e. g. potato cultivars capable ofsynthesizing these proteins with increased resistance against bacteriasuch as Erwinia amylvora). The methods for producing such geneticallymodified plants are generally known to the person skilled in the art andare described, for example, in the publications mentioned above.

The term “cultivated plants” is to be understood also including plantsthat are by the use of recombinant DNA techniques capable to synthesizeone or more proteins to increase the productivity (e. g. bio massproduction, grain yield, starch content, oil content or proteincontent), tolerance to drought, salinity or other growth-limitingenvironmental factors or tolerance to pests and fungal, bacterial orviral pathogens of those plants.

The term “cultivated plants” is to be understood also including plantsthat contain by the use of recombinant DNA techniques a modified amountof substances of content or new substances of content, specifically toimprove human or animal nutrition, for example oil crops that producehealth-promoting long-chain omega-3 fatty acids or unsaturated omega-9fatty acids (e. g. Nexera® rape).

The term “cultivated plants” is to be understood also including plantsthat contain by the use of recombinant DNA techniques a modified amountof substances of content or new substances of content, specifically toimprove raw material production, for example potatoes that produceincreased amounts of amylopectin (e. g. Amflora® potato).

Some of the mixtures of the invention have systemic action and cantherefore be used for the protection of the plant shoot against foliarpests as well as for the treatment of the seed and roots against soilpests.

Seed Treatment

Mixtures according to the present invention with systematic action aresuitable for the treatment of seeds in order to protect the seed frominsect pest, in particular from soil-living insect pests and theresulting plant's roots and shoots against soil pests and foliarinsects.

The protection of the resulting plant's roots and shoots is preferred.

More preferred is the protection of resulting plant's shoots frompiercing and sucking insects.

The present invention therefore comprises a method for the protection ofseeds from insects, in particular from soil insects and of theseedlings' roots and shoots from insects, in particular from soil andfoliar insects, said method comprising contacting the seeds beforesowing and/or after pregermination with mixtures according to thepresent invention. Particularly preferred is a method, wherein theplant's roots and shoots are protected, more preferably a method,wherein the plants shoots are protected from piercing and suckinginsects, most preferably a method, wherein the plants shoots areprotected from aphids.

The term seed embraces seeds and plant propagules of all kinds includingbut not limited to true seeds, seed pieces, suckers, corms, bulbs,fruit, tubers, grains, cuttings, cut shoots and the like and means in apreferred embodiment true seeds.

The term seed treatment comprises all suitable seed treatment techniquesknown in the art, such as seed dressing, seed coating, seed dusting,seed soaking and seed pelleting.

The present invention also comprises seeds coated with or containing theactive compound(s). The term “coated with and/or containing” generallysignifies that the active ingredient(s) are for the most part on thesurface of the propagation product at the time of application, althougha greater or lesser part of the ingredient may penetrate into thepropagation product, depending on the method of application. When thesaid propagation product is (re)planted, it may absorb the activeingredient.

Suitable seeds are seeds of cereals, root crops, oil crops, vegetables,spices, ornamentals, for example seed of durum and other wheat, barley,oats, rye, maize (fodder maize and sugar maize/sweet and field corn),soybeans, lima beans, oil crops, crucifers, cotton, sunflowers, bananas,rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants,potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks,pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons,Brassica species, melons, beans, peas, garlic, onions, carrots, tuberousplants such as potatoes, sugar cane, tobacco, grapes, petunias,geranium/pelargoniums, pansies and impatiens.

These crops are also particularly suitable for application of themixtures of the invention to growing plants.

In addition, the mixtures according to the invention may also be usedfor the treatment seeds from plants, which tolerate the action ofherbicides or fungicides or insecticides owing to breeding, includinggenetic engineering methods.

For example, the active mixtures can be employed in treatment of seedsfrom plants, which are resistant to herbicides from the group consistingof the sulfonylureas, imidazolinones, glufosinate-ammonium orglyphosate-isopropylammonium and analogous active substances (see forexample, EP-A-0242236, EP-A-242246) (WO 92/00377) (EP-A-0257993, U.S.Pat. No. 5,013,659) or in transgenic crop plants, for example cotton,with the capability of producing Bacillus thuringiensis toxins (Bttoxins) which make the plants resistant to certain pests (EP-A0142924,EP-A-0193259).

Furthermore, the mixtures according to the present invention can be usedalso for the treatment of seeds from plants, which have modifiedcharacteristics in comparison with existing plants consist, which can begenerated for example by traditional breeding methods and/or thegeneration of mutants, or by recombinant procedures). For example, anumber of cases have been described of recombinant modifications of cropplants for the purpose of modifying the starch synthesized in the plants(e.g. WO 92/11376, WO 92/14827, WO 91/19806) or of transgenic cropplants having a modified fatty acid composition (WO 91/13972).

The seed treatment application of the mixtures is carried out byspraying or by dusting the seeds before sowing of the plants and beforeemergence of the plants.

In the treatment of seeds the corresponding formulations are applied bytreating the seeds with an effective amount of the mixture according tothe present invention. Herein, the application rates of the activecompound(s) are generally from 0.1 g to 10 kg per 100 kg of seed,preferably from 1 g to 5 kg per 100 kg of seed, in particular from 1 gto 2.5 kg per 100 kg of seed. For specific crops such as lettuce therate can be higher.

Compositions, which are especially useful for seed treatment, are e.g.:

-   A Soluble concentrates (SL, LS)-   D Emulsions (EW, EO, ES)-   E Suspensions (SC, OD, FS)-   F Water-dispersible granules and water-soluble granules (WG, SG)-   G Water-dispersible powders and water-soluble powders (WP, SP, WS)-   H Gel-Formulations (GF)-   I Dustable powders (DP, DS)

Conventional seed treatment formulations include for example flowableconcentrates FS, solutions LS, powders for dry treatment DS, waterdispersible powders for slurry treatment WS, water-soluble powders SSand emulsion ES and EC and gel formulation GF. These formulations can beapplied to the seed diluted or undiluted. Application to the seeds iscarried out before sowing, either directly on the seeds or after havingpregerminated the latter

In a preferred embodiment a FS formulation is used for seed treatment.Typically, a FS formulation may comprise 1-800 g/l of activeingredient(s), 1-200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of asolvent, preferably water.

Preferred FS formulations of compounds of formula I for seed treatmentusually comprise from 0.1 to 80% by weight (1 to 800 g/l) of the activeingredient(s), from 0.1 to 20% by weight (1 to 200 g/l) of at least onesurfactant, e.g. 0.05 to 5% by weight of a wetter and from 0.5 to 15% byweight of a dispersing agent, up to 20% by weight, e.g. from 5 to 20% ofan anti-freeze agent, from 0 to 15% by weight, e.g. 1 to 15% by weightof a pigment and/or a dye, from 0 to 40% by weight, e.g. 1 to 40% byweight of a binder (sticker/adhesion agent), optionally up to 5% byweight, e.g. from 0.1 to 5% by weight of a thickener, optionally from0.1 to 2% of an anti-foam agent, and optionally a preservative such as abiocide, antioxidant or the like, e.g. in an amount from 0.01 to 1% byweight and a filler/vehicle up to 100% by weight.

Seed treatment formulations may additionally also comprise binders andoptionally colorants. Binders can be added to improve the adhesion ofthe active materials on the seeds after treatment. Suitable binders areblock copolymers EO/PO surfactants but also polyvinylalcoholsl,polyvinylpyrrolidones, polyacrylates, polymethacrylates, polybutenes,polyisobutylenes, polystyrene, polyethyleneamines, polyethyleneamides,polyethyleneimines (Lupasol®, Polymin®), polyethers, polyurethans,polyvinylacetate, tylose and copolymers derived from these polymers.

Optionally, also colorants can be included in the formulation. Suitablecolorants or dyes for seed treatment formulations are Rhodamin B, C.I.Pigment Red 112, C.I. Solvent Red 1, pigment blue 15:4, pigment blue15:3, pigment blue 15:2, pigment blue 15:1, pigment blue 80, pigmentyellow 1, pigment yellow 13, pigment red 112, pigment red 48:2, pigmentred 48:1, pigment red 57:1, pigment red 53:1, pigment orange 43, pigmentorange 34, pigment orange 5, pigment green 36, pigment green 7, pigmentwhite 6, pigment brown 25, basic violet 10, basic violet 49, acid red51, acid red 52, acid red 14, acid blue 9, acid yellow 23, basic red 10,basic red 108.

The invention also relates to seed comprising mixtures according to thepresent invention. The amount of the compound I or the agriculturallyuseful salt thereof will in general vary from 0.1 g to 100 kg per 100 kgof seed, preferably from 1 g to 5 kg per 100 kg of seed, in particularfrom 1 g to 1000 g per 100 kg of seed. For specific crops, e.g. such aslettuce, the rate can be higher. Also in some other cases the amount forseed treatment may be up to 100 kilogram of the active compound(s) per100 kilogram of seeds, or may even excess the seed weight.

EXAMPLES

A. Compounds

Bilobalide, ginkgolide A, ginkgolide B, ginkgolide C and ginkgolide Jare commercially available (e.g. from Interchim).

B. Biology

Synergism can be described as an interaction where the combined effectof two or more compounds is greater than the sum of the individualeffects of each of the compounds. The presence of a synergistic effectin terms of percent control, between two mixing partners (X and Y) canbe calculated using the Colby equation (Colby, S. R., 1967, CalculatingSynergistic and Antagonistic Responses in Herbicide Combinations, Weeds,15, 20-22):

$E = {X + Y - \frac{XY}{100}}$

When the observed combined control effect is greater than the expectedcombined control effect (E), then the combined effect is synergistic.

The following tests demonstrate the control efficacy of compounds,mixtures or compositions of this invention on specific pests. However,the pest control protection afforded by the compounds, mixtures orcompositions is not limited to these species. In certain instances,combinations of a compound of this invention with other invertebratepest control compounds or agents are found to exhibit synergisticeffects against certain important invertebrate pests.

The analysis of synergism or antagonism between the mixtures orcompositions was determined using Colby's equation.

The following abbreviations were used:

-   MTP: microtiter plate

Test 1

For evaluating control of boll weevil (Anthonomus grandis) the test unitconsisted of microtiter plates (MTPs) containing an insect diet and20-30 A. grandis eggs.

The compounds or mixtures were formulated using a solution containing75% water and 25% DMSO. Different concentrations of formulated compoundsor mixtures were sprayed onto the insect diet at 20 μl, using a custombuilt micro atomizer, at two replications.

For experimental mixtures in these tests identical volumes of bothmixing partners at the desired concentrations respectively, were mixedtogether.

After application, MTPs were incubated at 23±1° C., 50±5% room humidityfor 5 days. Egg and larval mortality was then visually assessed. For themixture tested the results are listed in Table 1.

TABLE 1 Calculated Active Observed efficacy compound/ Concentrationefficacy according to active mixture (ppm) Ratio (%) Colby (%)Dinotefuran 0.08 — 0 — Bilobalide 160 — 0 — Dinotofuran + 0.08 1:2000100 0 Bilobalide 160 Imidacloprid 0.8 — 25 — Bilobalide 160 — 0 —Imidacloprid + 0.8 1:2000 100 25  Bilobalide 160 Abamectin 0.003 — 0 —Bilobalide 64 — 25 — Abamectin + 0.003 1:21333 75 25  Bilobalide 64Imicacloprid 0.8 — 0 — Ginkgolide A 20 — 0 — Imidacloprid + 0.8 1:25 500 Ginkgloide A 20

Test 2

For evaluating control of Mediterranean fruitfly (Ceratitis capitata)the test unit consisted MTPs containing an insect diet and 50-80 C.capitata eggs. The compounds or mixtures were formulated using asolution containing 75% water and 25% DMSO. Different concentrations offormulated compounds or mixtures were sprayed onto the insect diet at 5μl, using a custom built micro atomizer, at two replications. Forexperimental mixtures in these tests identical volumes of both mixingpartners at the desired concentrations respectively, were mixedtogether. After application, MTPs were incubated at 28±1° C., 80±5% roomhumidity for 5 days. Egg and larval mortality was then visuallyassessed. For the mixture tested the results are listed in Table 2.

TABLE 2 Calculated efficacy Observed according Active compound/Concentration efficacy to active mixture (ppm) Ratio (%) Colby (%)Thiamethoxam 0.08 — 0 — Bilobalide 160 — 0 — Thiamethoxam + 0.08 1:200075 0 Bilobalide 160 Alphacypermethrin 0.4 — 0 — Bilobalide 160 — 0 —Alphacypermethrin + 0.4 1:4000 50 0 Bilobalide 160

Test 3

For evaluating control of tobacco budworm (Heliothis virescens) the testunit consisted of MTPs containing an insect diet and 15-25 H. virescenseggs. The compounds or mixtures were formulated using a solutioncontaining 75% water and 25% DMSO. Different concentrations offormulated compounds or mixtures were sprayed onto the insect diet at 10μl, using a custom built micro atomizer, at two replications. Forexperimental mixtures in these tests identical volumes of both mixingpartners at the desired concentrations respectively, were mixedtogether. After application, MTPs were incubated at 28±1° C., 80±5% roomhumidity for 5 days. Egg and larval mortality was then visuallyassessed. The results were listed in Table 3.

TABLE 3 Calculated efficacy Observed according Active compound/Concentration efficacy to active mixture (ppm) Ratio (%) Colby (%)Dinotefuran 0.08 — 0 — Bilobalide 400 — 0 — Dinotefuran + 0.08 1:5000 500 Bilobalide 400 Alphacypermethrin 0.08 — 0 — Bilobalide 400 — 0 —Alphacypermethrin + 0.08 1:5000 50 0 Bilobalide 400

Test 4

For evaluating control of yellow fever mosquito (Aedes aegypti) the testunit consisted of MTPs containing 200 μl water per well and 5-15 freshlyhatched A. aegypti larvae. The compounds or mixtures were formulatedusing a solution containing 75% water and 25% DMSO. Differentconcentrations of formulated compounds or mixtures were sprayed onto theinsect diet at 2.5 μl, using a custom built micro atomizer, at tworeplications. For experimental mixtures in these tests identical volumesof both mixing partners at the desired concentrations respectively, weremixed together. After application, MTPs were incubated at 28±1° C.,80±5% room humidity for 2 days. Larval mortality was then visuallyassessed. The results were listed in Table 4.

TABLE 4 Calculated efficacy Active compound/ Concentration Observedaccording to active mixture (ppm) Ratio efficacy (%) Colby (%)Thiamethoxam 0.8 — 50 — Bilobalide 160 — 0 — Thiamethoxam + 0.08 1:200100 50 Bilobalide 400

Test 5

For evaluating control of southern green stink bug (Nezara viridula) thecompounds or mixtures were formulated using a solution containingacetone and water (50:50) and 0.01% kinetic. Whole Green Beans arerinsed in a 1% bleach solution, triple rinsed with deionised water, andallowed to air dry at least 30 minutes in the fume hood. Beans weredipped in treatment solutions for 5 seconds and allowed to air dry for30 minutes in the fume hood. For maximum exposure, southern green stinkbug (4^(th) instar) were dipped in treatment solution for 3 seconds andallowed to air dry in a cup lined with filter paper and closed with avented lid for 10 minutes in the fume hood. Three beans were placed in500 ml deli cups with a 70 mm dry filter paper in the bottom and a 29.5ml portion cup with a cotton wick for water, and infested with 4southern green stink bug per cup. Each treatment was replicated 3-fold.Assay arenas were held at 27° C. and 45% room humidity. Data wererecorded after 5 days as number of insects alive, with dead recorded assuch and all others recorded as alive. The results were listed in Table5.

TABLE 5 Calculated Active efficacy compound/ Concentration Observedaccording to active mixture (ppm) Ratio efficacy (%) Colby (%) Spinosad10 — 17 — Ginkgolide A 5 — 58 — Spinosad + 10 2:1 92 65 Ginkgolide A 5Pyrethrum 10 — 25 — Ginkgolide A 5 — 58 — Pyrethrum + 10 2:! 92   68.5Ginkgolide A 5 Pyraclostrobin 10 — 0 — Ginkgolide A 5 — 58 —Pyraclostrobin + 10 2:1 67 58 Bilobalide 5 Fluxapyroxad 10 — 0 —Ginkgolide A 5 — 58 — Fluxapyroxad + 10 2:1 67 58 Ginkgloide A 5

Test 6

For evaluating control of different pathogens in a microtest the activecompounds were formulated separately as a stock solution having aconcentration of 10000 ppm in dimethyl sulfoxide.

The percentages were converted into efficacies. An efficacy of 0 meansthat the growth level of the pathogens corresponds to that of theuntreated control; an efficacy of 100 means that the pathogens were notgrowing.

The expected efficacies of active compound mixtures were determinedusing Colby's formula [R. S. Colby, “Calculating synergistic andantagonistic responses of herbicide combinations”, Weeds 15, 20-22(1967)] and compared with the observed efficacies.

Test 6-1. Activity against the late blight pathogen Phytophthorainfestans The stock solutions were mixed according to the ratios inTable 6, pipetted onto a MTP and diluted with water to theconcentrations in Table 6. A spore suspension of Phytophtora infestanscontaining a pea juice-based aqueous nutrient medium or DDC medium wasthen added. The plates were placed in a water vapor-saturated chamber ata temperature of 18° C. Using an absorption photometer, the MTPs weremeasured at 405 nm 7 days after the inoculation. The results were listedin Table 6.

TABLE 6 Calculated Active efficacy compound/ Concentration Observedaccording to active mixture (ppm) Ratio efficacy (%) Colby (%) Mancozeb0.063 — 39 — Bilobalide 1 — 24 — Mancozeb + 0.063 1:16 80 53  Bilobalide1 Mancozeb 0.016 — 15 — Bilobalide 0.25 — 4 — Mancozeb + 0.016 1:16 5418  Bilobalide 0.25 Mancozeb 0.004 — 0 — Bilobalide 0.063 — 0 —Mancozeb + 0.016 1:16 28 0 Bilobalide 0.25 Mancozeb 0.016 — 15 —Bilobalide 1 — 24 — Mancozeb + 0.016 1:63 62 35  Bilobalide 1 Mancozeb0.004 — 0 — Bilobalide 0.25 — 4 — Mancozeb + 0.004 1:63 23 4 Bilobalide0.25 Ametoctradin 0.004 — 0 — Bilobalide 0.25 — 4 — Ametoctradin + 0.0041:63 26 4 Bilobalide 0.25 Carbendazim 0.004 — 0 — Bilobalide 0.25 — 4 —Carbendazim + 0.004 1:63 29 4 Bilobalide 0.25 Iprodion 0.004 — 0 —Bilobalide 0.25 — 4 — Iprodion + 0.004 1:63 26 4 Bilobalide 0.25Prochloraz 0.016 — 3 — Bilobalide 0.25 — 4 Prochloraz + 0.016 1:16 26 6Bilobalide 0.25 Mancozeb 1 — 20 — Ginkgolide A 63 — 38 Mancozeb + 1 1:6397 51  Ginkgolide A 63

Test 6-2. Activity Against the Grey Mold Botrytis cinerea

The stock solutions were mixed according to the ratios in Table 7,pipetted onto a MTP and diluted with water to the concentrations inTable 7. A spore suspension of Botrci cinerea in an aqueous biomalt oryeast-bactopeptone-sodiumacetate solution was then added. The plateswere placed in a water vapor-saturated chamber at a temperature of 18°C. Using an absorption photometer, the MTPs were measured at 405 nm 7days after the inoculation. The results were listed in Table 7.

TABLE 7 Calculated efficacy Active compound/ Observed according toactive mixture Concentration Ratio efficacy (%) Colby (%) Chlorothalonil4 — 53 — Bilobalide 63 — 1 — Chlorothalonil + 4 1:16 95 56 Bilobalide 63Prochloraz 4 — 39 — Ginkgolide A 63 — 4 — Prochloraz + 4 1:16 80 41Ginkgolide A 63

Test 6-3. Activity Against Rice Blast Pyricularia oryzae

The stock solutions were mixed according to the ratios in Table 8,pipetted onto a MTP and diluted with water to the concentrations inTable 8. A spore suspension of Pyricularia oryzae in an aqueous biomaltor yeast-bactopeptone-glycerine solution was then added. The plates wereplaced in a water vapor-saturated chamber at a temperature of 18° C.Using an absorption photometer, the MTPs were measured at 405 nm 7 daysafter the inoculation. The results were listed in Table 8.

TABLE 8 Calculated Observed efficacy Active compound/ efficacy accordingto active mixture Concentration Ratio (%) Colby (%) Pyraclostrobin 0.016— 46 — Bilobalide 16 — 1 — Pyraclostrobin + 0.016 1:1000 80 46Bilobalide 16 Pyraclostrobin 0.016 — 46 — Bilobalide 4 — 3 —Pyraclostrobin + 0.016 1:250 73 47 Bilobalide 4 Azoxystrobin 0.25 — 45 —Bilobalide 63 — 5 — Azoxystrobin + 0.25 1:252 82 48 Bilobalide 63Azoxystrobin 0.25 — 45 — Bilobalide 16 — 1 — Azoxystrobin + 0.25 1:64 6945 Bilobalide 16 Chlorothalonil 0.25 — 13 — Bilobalide 16 — 1 —Chlorothalonil + 0.25 1:64 99 14 Bilobalide 16 Chlorothalonil 0.25 — 13— Bilobalide 4 — 3 — Chlorothalonil + 0.25 1:16 52 16 Bilobalide 4Trifloxystrobin 0.063 — 24 — Bilobalide 63 — 5 — Trifloxystrobin + 0.0631:1000 65 28 Bilobalide 63 Mancozeb 1 — 11 — Bilobalide 63 — 5 —Mancozeb + 1 1:63 98 16 Bilobalide 63 Chlorothalonil 0.25 — 15 —Ginkgolide A 4 — 0 — Chlorothalonil + 0.25 1:16 100 15 Ginkgolide A 4Chlorothalonil 0.25 — 15 — Ginkgolide A 16 — 0 — Chlorothalonil + 0.251:64 100 15 Ginkgolide A 16 Trifloxystrobin 0.063 — 24 — Ginkgolide A 16— 0 — Chlorothalonil + 0.063 1:1000 55 26 Ginkgolide A 16 Fenhexamid 1 —40 — Ginkgolide A 16 — 0 — Fenhexamid + 1 1:16 64 40 Ginkgolide A 16Pyrimethalin 4 — 27 — Ginkgolide A 63 — 3 — Pyrimethalin + 4 1:16 60 29Ginkgolide A 63

Test 6-4. Activity Against Leaf Blotch on Wheat Caused by Septoriatritici

The stock solutions were mixed according to the ratios in Table 9,pipetted onto a MTP and diluted with water to the concentrations inTable 9. A spore suspension of Septoria tritici in an aqueous biomalt oryeast-bactopeptone-glycerine solution was then added. The plates wereplaced in a water vapor-saturated chamber at a temperature of 18° C.Using an absorption photometer, the MTPs were measured at 405 nm 7 daysafter the inoculation. The results were listed in Table 9.

TABLE 9 Calculated efficacy Active compound/ Observed according toactive mixture Concentration Ratio efficacy (%) Colby (%)Trifloxystrobin 0.016 — 67 — Bilobalide 4 — 8 — Trifloxystrobin + 0.0161:250 99 70 Bilobalide 4 Trifloxystrobin 0.004 — 7 — Bilobalide 1 — 6 —Trifloxystrobin + 0.004 1:250 70 13 Bilobalide 1 Pyraclostrobin 0.004 —59 — Bilobalide 1 — 6 — Pyraclostrobin + 0.004 1:250 90 61 Bilobalide 1Epoxiconazol 0.25 — 35 — Bilobalide 16 — 9 — Epoxiconazol + 0.25 1:64 7040 Bilobalide 16 Prochloraz 4 — 49 — Ginkgolide A 63 — 16 — Prochloraz +4 1:16 83 57 Ginkgolide A 63

Test 6-5. Activity Against Early Blight Caused by Alternaria solani

The stock solutions were mixed according to the ratios in Table 10,pipetted onto a MTP and diluted with water to the concentrations inTable 10. A spore suspension of Alternaria solani in an aqueous biomaltor yeast-bactopeptone-glycerine solution was then added. The plates wereplaced in a water vapor-saturated chamber at a temperature of 18° C.Using an absorption photometer, the MTPs were measured at 405 nm 7 daysafter the inoculation. The results were listed in Table 10.

TABLE 10 Calculated efficacy Active compound/ Observed according toactive mixture Concentration Ratio efficacy (%) Colby (%) Fenhexamid 4 —46 — Bilobalide 16 — 0 — Fenhexamide + 4 1:4 77 48 Bilobalide 16Difenoconazol 1 — 0 — Bilobalide 63 — 0 — Difenoconazol + 1 1:63 34  0Bilobalide 63 Fluoxastrobin 0.25 — 11 — Ginkgolide A 63 — 0 —Fluoxastrobin + 0.25 1:252 81 11 Ginkgolide A 63 Epoxiconazol 0.25 — 36— Ginkgolide A 16 — 0 — Epoxiconazol + 0.25 1:63 66 36 Ginkgolide A 16Picoxystrobin 0.25 — 39 — Ginkgolide A 63 — 0 — Picoxystrobin + 0.251:252 61 39 Ginkgolide A 63

Test 6-6. Activity against wheat leaf spots caused by Leptosphaerianodorum

The stock solutions were mixed according to the ratios in Table 11,pipetted onto a MTP and diluted with water to the concentrations inTable 11. A spore suspension of Leptosphaeria nodorum in an aqueousbiomalt or yeast-bactopeptone-glycerine solution was then added. Theplates were placed in a water vapor-saturated chamber at a temperatureof 18° C. Using an absorption photometer, the MTPs were measured at 405nm 7 days after the inoculation. The results were listed in Table 11.

TABLE 11 Calculated efficacy Active compound/ Observed according toactive mixture Concentration Ratio efficacy (%) Colby (%) Chlorothalonil1 — 39 — Ginkgolide A 63 — 18 — Chlorothalonil + 1 1:63 70 50 GinkgolideA 63 Difenoconazol 1 — 21 — Bilobalide 63 — 24 — Difenoconazol + 1 1:6376 40 Bilobalide 63

Test 7

Compatibility of bilobalide with Beauveria bassiana strain PPRI 5339 wasanalyzed. Aqueous mixtures containing 100 ppm of bilobalide, and 4×10E7CFU/ml of Beauveria bassiana strain PPRI 5339 were filled in bottles.Bottles were shaken to assertain complete dilution and incubated at roomtemperature (26° C.). The aqueous mixtures were maintained for 1 hour,or 24 hours. Ten-fold serial dilutions were made for both incubationtimes from 1:10E0 to 1:10E10. A fixed volume (100 μl) of each dilutionwas distributed aseptically onto petri dishes containingDichloran-Rose-Bengal-Chlortetracycline agar for culture. Petri disheswere incubated in a dark chamber at 28° C. for five days and submittedto visual inspection. Analyzed parameters were the number of colonies,colony diameter, shape, color, and speed of growth. The results showedthat Beauveria bassiana strain PPRI 5339 and Bilobalide were compatibleunder all tested conditions.

For evaluating control of southern green stink bug (Nezara viridula),Bilobalide, Beauveria bassiana strain PPRI 5339, or mixtures thereofwere formulated using a solution containing water and acetone(98.75:1.25). Beauveria bassiana strain PPRI 5339 was at roomtemperature for one hour before use.

Seven days old Lima bean plants were dipped into each treatment. Oncedried, plants were artificially infested with four second instarsouthern green stink bugs. Percentage of mortality (sick+death insects)was evaluated at 5 days. The results were listed in Table 12.

TABLE 12 Calculated Active efficacy compound/ Observed according activeefficacy to Colby mixture Concentration Ratio (%) (%) Beauveria 4 × 10E7CFU/ml — 37 — bassiana strain PPRI 5339 Bilobalide 50 ppm — 33 —Beauveria 4 × 10E7 CFU/ml 2 × 10E5 100 58 bassiana 50 ppm CFU/ml:1 ppmstrain PPRI 5339 + Bilobalide

1. (canceled)
 2. A pesticidal mixture comprising as active compounds 1)at least one compound (I), which is a component of the ginkgo treeselected from the group consisting of bilobalide, ginkgolide A,ginkgolide B, ginkgolide C, ginkgolide J, and ginkgolide M; and 2) atleast one pesticidally active compound (II) selected from the group ofneonicotinoids consisting of acetamiprid, clothianidin, cycloxaprid,dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam in asynergistically effective amount, wherein the weight ratio of compound(I) and compound (II) is from 7500:1 to 1:5.
 3. The pesticidal mixtureof claim 2, wherein the weight ratio of compound (I) to compound (II) isfrom 5000:1 to 1:5.
 4. A seed treated with the mixture of claim 2 in anamount of from 0.1 g to 100 kg per 100 kg of seed.
 5. A pesticidalcomposition comprising a liquid or solid carrier and the mixture ofclaim
 2. 6. A method for controlling pests from the family ofPentatomidae, comprising the step of contacting the pests, their foodsupply, habitat or breeding grounds with the mixture of claim
 2. 7. Themethod of claim 6, wherein the Pentatomidae are selected fromAcrosternum spp., Euschistus spp., Nezara spp. and Piezodrus spp.
 8. Themethod of claim 6, wherein the Pentatomidae are selected fromAcrosternum hilare, Euschistus heros, Nezara viridula, Piezodrusguildini, Halyomorpha halys and Dichelops spp.